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Executive Summary 
 
Promoting and protecting the health of Iowans is the mission of the Iowa Department of Public Health 
(IDPH). Surveillance of notifiable health conditions is essential in establishing what, how, and when 
events impact the public’s health. Multiple divisions and bureaus are dedicated to accomplishing the 
goals of surveillance. In 2013, there were more than 71,000 laboratory results of infectious diseases and 
conditions submitted to IDPH disease surveillance programs. IDPH also investigates non-infectious 
conditions related to lead, occupational, and environmental hazards like carbon monoxide. 
Approximately 68,000 children’s and more than 3,000 adult’s blood tests results were reported to IDPH 
in 2013. 
 
In general, the number of reported cases of vaccine-preventable diseases decreased when compared to 
the previous three-year average (2010-2012); however, the number of reported hepatitis A cases 
increased. 
 
Enteric diseases like cryptosporidiosis, cyclosporiasis, giardiasis, salmonellosis, and shigellosis increased 
when compared to the previous three year average. During the summer of 2013, 136 Iowans from 35 
counties were diagnosed with cyclosporiasis and met the case definition as part of a multi-state 
outbreak linked to consumption of a bagged salad mix. Cyclospora is a rare coccidian parasite that can 
cause prolonged and relapsing watery diarrhea, which, if left untreated, can last weeks to months. Only 
10 cases of Cyclospora had been reported in Iowa prior to 2013. In addition to the Cyclospora outbreak, 
59 other outbreaks affecting more than 1,100 people were reported and investigated in 2013. The most 
common implicated pathogen was norovirus and outbreaks occurred most frequently in restaurants, 
long-term care/assisted living facilities, schools/child care facilities, and homes. 
 
Diseases spread via insects continue to impact Iowans. In 2013, there were a notable number of these 
diseases reported to IDPH including Dengue fever, ehrlichiosis/anaplasmosis, Lyme disease, malaria, 
Rocky Mountain spotted fever, and West Nile virus. Of these diseases, Lyme disease, 
ehrlichiosis/anaplasmosis, and West Nile virus increased when compared to the previous three-year 
average. 
 
While the number of gonorrhea and chlamydial diagnoses remain relatively stable, diagnoses of syphilis 
have increased substantially. HIV diagnoses in 2013 increased slightly from 2012, but remained below 
the peak of 126 in 2009. In 2013, 122 Iowans were diagnosed with HIV, five more than in 2012, and six 
more than the five-year average of 116. Of concern is over 40 percent of persons diagnosed in 2013 
were considered to be late testers, that is, persons who met the criteria for AIDS within 12 months of 
their initial HIV diagnosis. Late testers have generally been infected and infectious for many years, and 
during that time have had the opportunity to unknowingly infect others with the virus. They generally 
have higher viral loads and are more infectious than are persons who have been diagnosed early, are in 
care, and have a very low viral load as the result of successful treatment with antiretroviral medications. 
In 2012, only 21 females were diagnosed with HIV; in 2013 the number increased to 34, a 62 percent 
jump from both 2012 and the five-year average. It is, however, important to keep in mind that large 
percentage increases in relatively small numbers must always be viewed with caution. Several years of 
data will be needed to establish if 2013 marks the beginning of a trend. 
 
Diagnoses among Iowans 45 years and older reached an all-time high of 50 diagnoses in 2013.  Iowans 
25 to 44 years of age accounted for 44 percent of all diagnoses; those 45 and older made up 41 percent; 
and youths ages 15 to 24 years made up the remaining 15 percent. When compared to their proportions 
in the general population of the state, racial and ethnic minorities continued to be over-represented  
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among Iowans diagnosed with HIV. Non-Hispanic black/African-American persons, 3 percent of Iowa’s 
population, represented 23 percent of new diagnoses. Hispanics, 5 percent of the general population, 
represented 7 percent of new diagnoses. Non-Hispanic Asians, 2 percent of the general population, 
made up 7 percent of new diagnoses. Of the 45 diagnoses among racial and ethnic minorities, 27 (60 
percent) were among foreign-born persons. Regardless of such disparities, it is important to remember 
that non-Hispanic white Iowans accounted for over 60 percent of new HIV diagnoses and persons living 
with HIV/AIDS. The number of Iowans living with HIV or AIDS (HIV disease prevalence) continues to 
increase. As of December 31, 2013, there were 2,100 persons living with HIV, a prevalence of 68 per 
100,000 population. In 2012, there were 2,023 persons, a prevalence of 66 per 100,000 population. 
 
Crucial partners contributing to the surveillance and reduction of these diseases include the State 
Hygienic Laboratory (SHL) at the University of Iowa, clinical laboratories, hospitals, city and county public 
health agencies, long-term health care facilities, schools, as well as healthcare providers, infection 
preventionists and other health professionals. The Iowa Department of Public Health would like to take 
this opportunity to thank all of its partners for their continued support of disease surveillance in Iowa.    
 
Table 1. Summary of notifiable diseases 2010-2013 and 
percent change in number of cases reported compared to a three-year average 
  2010 2011 2012 
3-yr average 
2010-2012 2013 
Percent 
change† 
  Number of cases ǂ    
Campylobacteriosis 751 747 534 677 610 -9.9% 
Chlamydia 10542 10928 11139 10870 11006 1.3% 
Cryptosporidiosis 397 364 328 363 1505 314.6% 
E. coli and other shiga-toxin producing  173 189 181 181 171 -5.5% 
Giardiasis 284 271 251 269 275 2.4% 
Gonorrhea 1804 1966 1982 1917 1473 -23.2% 
Hepatitis A 11 8 7 9 17 96.2% 
Hepatitis B, acute 15 15 12 14 11 -21.4% 
HIV (new diagnoses) 115 119 117 117 122 4.3% 
lead poisoning (child) * * * *     321 * 
lead poisoning (adult) 736 832 818 795 856 7.7% 
Legionellosis 16 11 13 13 11 -17.5% 
Listeriosis 3 5 3 4 2 -45.5% 
Lyme disease 87 100 165 117 247 110.5% 
Meningococcal invasive disease 10 14 2 9 1 -88.5% 
Mumps 38 8 6 17 3 -82.7% 
Pertussis (whooping cough) 705 232 1736 891 308 -65.4% 
Salmonellosis 530 448 622 533 575 7.8% 
Shigellosis 57 18 91 55 342 518.1% 
Syphilis 68 70 138 92 226 145.7% 
†The percent change is calculated by subtracting the 3-year average from the total cases for 2012 and dividing by the absolute value of the 3-
year average.  
ǂ Table includes all confirmed and probable cases.  
* Due to current changes in determining cases of lead poisoned children, case counts prior to 2013 are being revised and were not available at 
the time this report was published. 
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Introduction 
The purpose of this report is to provide a snapshot of the types and trends of notifiable and other 
diseases that occur in Iowa. When possible, details specific to the disease are provided, including 
information on which serotypes, strains or groups were prevalent, and which caused outbreaks. 
Comparisons to national rates are also provided whenever possible. Aggregated county-level data are 
provided in a table at the end of the report. The report is intended for use by the public, media, public 
health, and health care.  
 
The report is divided into the following sections: respiratory and vaccine-preventable diseases; sexually-
transmitted diseases; human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome 
(AIDS); hepatitis C; enteric diseases; zoonotic diseases; rare and unusual diseases; and environmental 
health conditions.  
 
The Iowa Department of Public Health (IDPH) has five divisions and of those, two contributed disease 
data to this report, including Behavioral Health (BH) and Acute Disease Prevention and Emergency 
Response  and Environmental Health (ADPER & EH). The Division of Behavioral Health includes the 
Bureau of HIV, Sexually Transmitted Disease (STD), and Hepatitis which identifies, monitors, and 
supports persons with HIV/AIDS, STDs, and viral hepatitis. Disease reporting and tracking are a large 
component of the work accomplished by this bureau, as well as locating, counseling, and testing 
partners of persons with sexually transmitted diseases. 
 
The Division of Acute Disease Prevention and Emergency Response, and Environmental Health (ADPER & 
EH) has six bureaus and of those, three bureaus contributed data to this report. Two bureaus are 
responsible for infectious disease investigation: the Center for Acute Disease Epidemiology (CADE) and 
the Bureau of Immunization and Tuberculosis (BIT). CADE conducts surveillance for common and 
emerging infectious diseases, agents of bioterrorism, disease outbreaks, and occurrence of rare and 
unusual acute diseases. BIT conducts surveillance for tuberculosis and perinatal hepatitis B, as well as 
coordinates the immunization program for the state. Specific disease conditions are reportable to the 
department per Iowa Administrative Code 641, Chapter 1. The urgency tied to reporting varies by 
disease1.  
 
The third ADPER & EH reporting bureau is the Bureau of Environmental Health Services (EHS), which is 
responsible for environmental health conditions investigation. Certain health conditions of 
environmental origin are required to be reported to IDPH per Iowa Administrative Code 641, Chapter 1. 
This report includes disease/outbreak surveillance, carbon monoxide poisoning, methemoglobinemia, 
child and adult blood lead levels, reports of other heavy metal poisonings, and fatal work-related 
traumatic injuries.  
 
Public health emergency response planning plays a major role in preparing IDPH to respond to events of 
public health significance. In the past several years, the department used the incident management 
system in response to several events, including severe weather in 2008 and the 2009 H1N1 pandemic. 
Preparedness planning at both the state and local levels has greatly improved the ability of public health 
to respond to large-scale disease outbreaks as well as natural disasters.  
 
This report provides an overview of disease investigations and represents only a fraction of work 
accomplished by IDPH staff each year. The time invested in each disease report varies greatly by disease 
and nature of the report. Some reports require a quick database query and update of an electronic file. 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
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Others require hours of staff time in contact tracing, mentoring and assisting other health investigators, 
and communication, education, and implementation of interventions.  
 
Support for the initiatives of the ADPER & EH division comes from a variety of federal and state 
allocations and grants. The TB, STD, and HIV/AIDS surveillance programs are funded under separate 
cooperative agreements with the Centers for Disease Control and Prevention (CDC) and the National 
Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention. 
 
Methods 
Disease reports are submitted to IDPH via phone, fax, mail, or a secure electronic reporting system. 
Reporters include health care providers, hospitals, local public health agencies, laboratories, and the 
public. CADE tracks reports of disease in Iowa residents; however, acquisition or exposure to some 
illnesses may have occurred in Iowa, another state, or outside of the United States. 
 
Reports received by CADE are tracked in the secure web-based Iowa Disease Surveillance System (IDSS). 
De-identified data are electronically exchanged between IDSS and CDC. Electronic laboratory reports are 
sent from the State Hygienic Laboratory (SHL) at the University of Iowa directly to IDPH via IDSS daily.   
 
Cases of acute infectious disease are typically referred to local public health agencies for patient 
investigations and interviews. Agencies primarily use IDSS to report information back to IDPH. Local 
public health agencies are also critical in conducting outbreak investigations. These agencies work to 
identify, investigate, and contain outbreaks at the city and county level.  
 
A few diseases require a secondary reporting system used by IDPH for transmitting data to program-
specific staff at CDC. These diseases include influenza and West Nile virus. The National Outbreak 
Reporting System (NORS) is a CDC-sponsored system used by IDPH to report outbreaks.  
 
Rates were calculated using the 2010 census population for the State of Iowa or the appropriate 
estimated census year. The enteric disease five-year averages were calculated by taking the average of 
the previous five years’ case counts for each disease. This is in contrast to previous methods utilized in 
this report which included adding the five year average to two times the standard deviation (5-year 
average + 2(SD)). All case counts include cases that were and were not considered to be part of an 
outbreak investigation. This also differs from previous methods utilized in this report. Calculations were 
performed with SPSS® 16, SAS® 9.3, and Microsoft® Excel. Maps were generated using ARC GIS ®.  
 
CADE uses the most recent Council of State and Territorial Epidemiologists (CSTE)/CDC case definitions 
found at https://wwwn.cdc.gov/nndss/case-definitions.html .CSTE/CDC definitions are used to classify 
each case as confirmed, probable, suspect, not a case, or awaiting more information. Only confirmed 
and probable cases meeting the CSTE/CDC definitions are included in this report.  
 
Disease case counts and Iowa-specific case demographics were retrieved from IDSS, which is maintained 
within CADE. The specific file used for this report was created in April 2014. Case reports and additional 
information received after this date that may have altered the disease counts were not included in this 
report. In addition, the data file was generated using MMWR (Morbidity Mortality Weekly Report) year 
2013. Therefore, case counts in this report may vary slightly from counts generated using the calendar 
year of 2013. 
 
Influenza surveillance data were collected from multiple sources, including outpatient health care 
providers, hospitals, public health, clinical laboratories, and schools. Laboratory-confirmed influenza 
Iowa Department of Public Health 
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cases were based on real-time polymerase chain reaction (RT-PCR) test results sent from SHL. SHL also 
surveyed clinical and reference labs throughout the state for the weekly number of rapid influenza tests 
performed and number of positives. Influenza-associated hospitalizations were reported from the 
sentinel hospitals that participated in the Iowa Influenza Surveillance Network (IISN).  
 
Respiratory syncytial virus (RSV) rapid antigen test data are used to determine the weekly positive 
predictive value of the rapid antigen tests in Iowa. SHL surveyed clinical and reference labs throughout 
the state for the number of rapid-antigen tests performed and number positive weekly, and sent the 
survey results to IDPH. 
 
The surveillance case definitions for HIV, AIDS, STDs, and TB are those developed through the 
collaboration of the Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease 
Control and Prevention (CDC). Surveillance is conducted according to detailed guidelines developed by 
CDC. Several programs enter data into CDC-developed software programs. Programs transfer data via a 
secure data network on a weekly or monthly basis. HIV/AIDS data are collected in a CDC-developed 
software program called the enhanced HIV and AIDS Reporting System (eHARS). 
 
For accuracy of analysis, and because jurisdiction for HIV and AIDS cases is determined by the person’s 
residence at the time of diagnosis, great care is taken both within and between states to maintain 
unduplicated databases for HIV and AIDS. 
 
With regard to HIV/AIDS surveillance, reports are generated semi-annually, and as needed. An 
epidemiological profile is produced every three years, with annual interim updates2. HIV/AIDS data 
analysis for this report used a combination of CDC’s eHARS software, Microsoft® Excel, SAS®, and SAS® 
Enterprise Guide.  
 
In 2010, the STD program began using IDSS for surveillance of syphilis, Chlamydia, and gonorrhea. Prior 
to 2010, the STD program entered data in a CDC database called STD*MIS or the STD Management 
Information System.  
 
Environmental Health Services began using IDSS in 2010 for surveillance of heavy metals, carbon 
monoxide, and methemoglobinemia. The results of all blood lead testing done on Iowa residents are 
required to be reported to the EHS bureau. Data are entered into a CDC-designed database called 
STELLAR, with separate databases maintained for child and adult data. Data analysis is performed 
periodically for reporting to state and national partners.  
 
Most disease-specific data are transmitted to CDC electronically on a routine basis after being de-
identified. Some disease information is communicated at the request of CDC. The statistics reported by 
ADPER programs to CDC are used to develop a composite picture of disease burden in the US.  
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Summary of respiratory and vaccine-preventable diseases 
 
Haemophilus influenzae B 
Cases of Haemophilus influenzae type B (Hib), invasive disease are rare in Iowa and the US today. In 
1991, Hib vaccine was recommended for all infants after age 2 months. Since then, the incidence of Hib 
in children less than 5 years of age declined by greater than 99 percent; in 2013, only one case of 
Haemophilus influenzae type B reported to IDPH.  
 
Hepatitis A 
See Summary Enteric Disease Section. 
 
Hepatitis B (acute and chronic) 
Hepatitis B is caused by infection with the Hepatitis B virus. Hepatitis B is usually spread when blood, 
semen, or another body fluid from a person infected with the Hepatitis B virus enters the body of 
someone who is not infected. This can happen through sexual contact with an infected person or 
sharing needles, syringes, or other drug-injection equipment. Hepatitis B can also be passed from an 
infected mother to her baby at birth. 
 
Hepatitis B can be either acute or chronic. Acute hepatitis B virus infection is a short-term illness that 
occurs within the first six months after someone is exposed to the virus. Chronic hepatitis B virus 
infection is a long-term illness that occurs when the virus remains in a person’s body. Chronic hepatitis B 
is a serious disease that can result in long-term health problems and even death. 
 
A total of 11 cases or 0.4 cases for every 100,000 persons of acute hepatitis B were reported to CADE in 
2013. Sixty-four percent of the cases were females. Nationally, acute hepatitis B infections occur 1.8 
times more often in men than in women.  
 
The Centers for Disease Control and Prevention (CDC) estimates there were 43,000 new hepatitis B 
infections in the U.S. in 2007, and between 800,000 and 1.4 million people living with chronic hepatitis B 
disease in the US. 
 
There were 276 confirmed or probable chronic hepatitis B cases reported in 2013 in Iowa. Fifty-five 
percent of the cases were males and 45 percent were females. 
 
Influenza  
The Iowa Influenza Surveillance Network (IISN) tracks influenza activity, age groups impacted, outbreaks, 
virus type and strain, and severity of seasonal influenza. During the 2013-2014 season, more than 250 
surveillance sites reported to IISN, including medical clinics, hospitals, laboratories, schools, local public 
and health departments. IDPH analyzed the data reported from the surveillance sites and published the 
influenza weekly report during the season. To see the weekly report, visit 
https://idph.iowa.gov/influenza/reports.  
 
The 2013-2014 influenza season in Iowa started earlier and was less severe than in 2012-13. The first 
case of seasonal influenza was confirmed by the State Hygienic Laboratory (SHL) in September, 2013. 
Influenza activity increased in December and peaked in early January, 2014 (Figure 1-3). SHL identified 
three seasonal influenza viruses circulating in Iowa for the season: influenza A (H3N2), influenza A (2009 
H1N1) and influenza B. Influenza A (H1N1) viruses were predominant in Iowa, accounting for 87 percent 
of all positive influenza specimens tested. Four hundred ninety influenza-associated hospitalizations 
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were reported from 33 sentinel hospitals for the season and 51 percent of the hospitalizations were 
among people between 25 to64 years of age.  
 
Figure 1. Laboratory-confirmed cases of influenza reported to IDPH, 2013-2014 
 
 
Figure 2. Percent of rapid influenza tests positive and number of tests performed, 2013-2014 
 
 
Figure 3. Influenza-associated hospitalizations reported from sentinel hospitals, 2006-2014 
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LEGIONELLOSIS 
The average number of Legionella cases reported to IDPH annually from 2010 to 2012 was 13 cases. 
There were 11 cases of legionellosis reported to IDPH in 2013.  Most of the cases occurred in Central 
and Eastern Iowa.  Cases ranged from ages 30 to 92 years with a median age of 64 years.  All of the 11 
cases that occurred in 2013 were hospitalized, and there were no reported deaths. 
 Legionellosis disease summary amended 9/25/2014 
Measles 
There was one confirmed case reported in 2011, but there were no cases of measles reported to IDPH in 
2012 and 2013.  
 
Meningococcal invasive disease 
There was one confirmed case of meningococcal invasive disease reported to IDPH in 2013, which 
occurred in an elderly female. The case was group C (Table 2). Nationally, there are 0.36 cases for every 
100,000 persons.
 
Table 2. Cases of meningococcal disease by 
serogroups, 2013 
A B* C W135 Y Unk 
0    0 1 0 0 0 
*Serogroup B is not covered by the meningococcal vaccine
 
CDC defines a community-based outbreak of meningitis as the occurrence of three or more confirmed or 
probable cases during a period of less than or equal to three months among persons residing in the 
same area, are not close contacts of each other, and do not share a common affiliation, with a primary 
attack rate of at least 10 cases per 100,000 population3.There were no outbreaks in Iowa in 2013.  
 
Meningococcal invasive disease is fatal in 10-14 percent of cases; however, no Iowa case was fatal in 
2013.There are two types of meningococcal-vaccines currently licensed for use in the US: 1) a 
polysaccharide vaccine and 2) a conjugated vaccine. 
 
Mumps 
In 2013, there were three cases of mumps or 0.1 cases per 100,000 persons, an 83 percent decrease 
over the previous three-year average of 17. Case ages in 2013 ranged from 3 to 27 years with a median 
age of 12 years. There were no outbreaks in Iowa in 2013. 
 
In 2006, Iowa was the center of the largest mumps outbreak in 20 years in the US with 1,963 confirmed 
and probable cases. Prior to 2006, most cases were typically imported from countries with endemic 
disease.  
 
Pertussis (Whooping cough) 
Pertussis is caused by Bordetella pertussis and before the vaccine era, typically caused epidemics every 
three to five years. In 2013, there were 308 confirmed and probable cases reported to IDPH or 10.1 
cases for every 100,000 persons in Iowa, as compared to 1,736 cases or 57 cases for every 100,000 
persons in Iowa in 2012, which was at the highest level since 2003 (Figure 4). 
 
Seventy-four percent of 2013 cases occurred in children ages 0 to 14. Five percent of pertussis cases 
were hospitalized, and no deaths were reported. The year’s highest rates occurred in Davis, Adams, 
Taylor, Wayne, and Carroll counties (Figure 5).  
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The most common symptoms are paroxysms (fits of coughing, 78 percent), followed by post-tussive 
vomiting (43 percent), whooping (26 percent) and apnea (14 percent). Rare, but serious secondary 
conditions reported included pneumonia, and encephalopathy. 
 
Figure 4. Number of pertussis cases reported to IDPH by month and year, 2003-2013 
 
Figure 5. Pertussis rates by county, 2013 
 
 
Respiratory Syncytial Virus (RSV) 
Sentinel surveillance for respiratory syncytial virus began in 2008. IDPH and SHL solicit rapid RSV test 
results from clinical and reference labs throughout the state to determine the percentage of positive 
test results of those performed (Figure 6). In addition, various labs, including SHL, report polymerase 
chain reaction (PCR) or culture confirmation of RSV as a means to verify the presence of RSV in Iowa. 
The CDC considers RSV widespread in the population when the percent of rapid antigen tests that are 
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positive exceeds 10 percent. During the 2013-2014 season in Iowa, this occurred in mid-December, and 
the activity peaked in Week 10 ending March 8, 2014. 
 
Nationally, RSV surveillance is conducted by CDC using data from the National Respiratory and Enteric 
Virus Surveillance System. Data are reported from sentinel laboratories throughout the US on a 
voluntary basis. Recent research has highlighted variability among different regions and states in the 
US4.  
Figure 6. Percent of rapid RSV tests positive and number of tests performed, 2013-2014
 
 
 
Tuberculosis (TB) 
In 2013, Iowa reported 47 cases of active TB disease. Since 2004, Iowa has averaged 45 cases of TB each 
year (Figure 7). Many cases have existing co-morbidities that make TB treatment considerably more 
complex and require extensive care, including the use of second-line drugs. Treatment with second-line 
drugs is complicated and expensive, requiring expert consultation and extended treatment durations.  
 
Figure 7. Number of Iowa TB cases by year, 2004-2013 
 
 
Counties with larger population centers such as Polk, Woodbury, and Black Hawk report the majority of 
TB cases. However, as Figure 8 illustrates, many (52/99) Iowa counties reported TB cases during 
calendar years 2004-2013. 
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Figure 8. Iowa counties with TB cases 2004-2013 
 
 
 
The 2013 TB case rate for Iowa is 1.5 cases per 100,000 persons; this is significantly lower than the 2012 
national average of 3.2 cases per 100,000 persons.  Iowa owes its low TB case rate in part to proficient 
contact investigations, healthcare providers observance of treatment guidelines, adherence to DOT for 
active disease cases, and the provision of medication for LTBI to thousands of Iowans annually. 
 
The proportion of reported TB cases in non-U.S. born persons has increased significantly in the past two 
decades. In 1995 for example, non-U.S. born persons accounted for 38 percent of reported TB cases in 
Iowa. From 2004 to 2013, non-U.S. born persons accounted for 67 percent of reported TB cases in Iowa 
(figure 14).   
 
Non-U.S. born persons account for only four percent of the Iowa population, highlighting the disparity.  
The decreasing numbers of U.S. born cases are due in part to effective TB control practices in this 
country. 
 
Figure 9. Percent of US-born versus non-US-born TB cases in Iowa, 2004-2013 
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In many parts of the developing world, TB is still widespread and remains a leading cause of death. 
Immigration of people from these countries to the United States illustrates how what happens in one 
part of the world can directly impact other parts of the world. Effective targeted testing programs for 
newly arriving refugees, immigrants, and students play a major role in identifying and treating these 
populations.  
 
Country of Origin Data  
For 2013, 33 individuals emigrating from 18 countries (excluding the U.S.) developed TB in Iowa. Figure 
15 represents 308 individuals, emigrating from 52 countries (excluding the U.S.) that developed TB 
disease after their arrival to Iowa during 2004 to 2013. As the map illustrates, TB anywhere is TB 
everywhere. Approximately 95 percent of all patients with active TB disease live in the developing 
world, where 99 percent of all TB deaths occur. TB is a good example of the global nature of public 
health. It is important to implement consistent and aggressive public health measures to halt TB disease, 
which left untreated, kills half of its victims. 
For a detailed overview of TB, see https://idph.iowa.gov/immtb/tb.  
 
Figure 10. Iowa TB cases by country of origin 2004-2014 
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Summary of sexually transmitted diseases, HIV and AIDS, and hepatitis C 
 
HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNODEFICIENCY 
SYNDROME (AIDS) 
Although there has been year-to-year variability, HIV diagnoses have been increasing at a rate of about 
1.4 per year since 2004. There were 122 HIV diagnoses in 2013, an increase of five (4 percent) from the 
117 diagnoses reported in 2012, and six (5 percent) more than the average of 116 for the previous five 
years. In 2013, there were 4.0 HIV diagnoses per 100,000 population, compared to 3.HIV diagnoses per 
100,000 population in 2012 and 2011, respectively. Figure 11 charts the number of HIV diagnoses by 
year for the years 2004 through 2013. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
A person who is diagnosed with AIDS within 12 months of initial HIV diagnosis is termed a “late tester.”  
Given this definition, 2012 is the most recent year for which complete late tester analysis is available.  
After peaking at 61percent in 2001, late testers as a proportion of all HIV diagnoses for a given year 
declined over time to 35 percent in 2011, only to climb again to 39 percent in 2012. Late testers have 
generally been infected for many years and during that time have had the opportunity to unknowingly 
infect others with the virus. They generally have higher viral loads and are more infectious than are 
persons who have been diagnosed early, are in care, and have a very low viral load as the result of 
successful treatment with antiretroviral medications. While preliminary analysis of 2013 data indicates 
late testers already account for 48 percent of the 122 persons diagnosed, final analysis can’t be 
completed until December 2014. Late tester status may be more an indication of prevention failure than 
of treatment failure or access to care. 
 
Diagnoses of HIV among the foreign-born reached a 10‐year high in 2010, when 28 (24 percent) of the 
119 persons diagnosed with HIV were foreign-born. In 2012, there were 20 (17 percent) diagnoses 
among the foreign-born, matching the average for the five years from 2008 through 2012. By 
comparison, 27 (22 percent) of the 122 persons diagnosed in 2013 were born in a country other than 
the United States or one of its dependencies. While IDPH does not monitor the immigration status of 
persons diagnosed with HIV, resettlement of refugees in Iowa and secondary migration of immigrants 
from areas of the world with higher prevalence of HIV may be contributing to diagnoses among Iowa’s 
population of foreign-born.  
 
  Figure 11.  Number of Iowans diagnosed with HIV by year, 2004-2013 
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While males have always accounted for the majority of HIV diagnoses; the disproportionation peaked in 
2009 and the gap has since begun to narrow Diagnoses among males increased steadily from 78 in 2004 
to 105 in 2009. After that they remained relatively steady, averaging 97 per year from 2010 through 
2012. Then, in 2013, diagnoses in males dropped to 88, accounting for 72 percent of HIV diagnoses. In 
contrast, diagnoses among females decreased from 27 in 2004 to 20 in 2006, hovered around that mark 
through 2012, and then climbed from 21 in 2012 to 34 in 2013, a 62 percent jump. Several years of data 
needed to establish if 2013 marks the start of a trend that warrants action. From 2006 through 2012, 
there were about five male diagnoses for every one female diagnosed. This is in contrast to a ratio of 
three males to one female in 2013.   
 
The data for 2013 notwithstanding, the gradual increase in HIV diagnoses since 2004 can be attributed 
to increases in diagnoses among males. The increases have been most remarkable among persons 15 to 
24 years of age and 45 years and older. For the past five years (2009 through 2013), diagnoses among 
persons 15 to 24 years of age have averaged 22 per year, compared to the previous five-year average of 
14 diagnoses per year from 2004 to 2008. Eighteen persons aged 15 to 24 years were diagnosed in 2013, 
down from the peak of 28 in 2008 and the 21 diagnosed in 2012. Encouragingly, 2013 was the first year 
since 2006 in which diagnoses among 15 to 24 year olds numbered less than 20. Not so encouraging, 
however, was the 52 percent jump in diagnoses among persons 45 years and older, from 33 in 2012 to 
50 in 2013. Diagnoses in this age group had increased steadily from 24 in 2004 to a peak of 39 in 2007, 
and then stabilized at an average of 32 diagnoses per year from 2008 through 2012, before accelerating 
in 2013 to their highest number ever. While diagnoses in the aforementioned groups are concerning, it 
is important not to lose sight of the fact that diagnoses among persons 25 to 44 years of age accounted 
for nearly half of all diagnoses, with 54 (44 percent) persons diagnosed in 2013. Persons ages 45 and 
older accounted for 41 percent of all diagnoses, while persons ages 15 to 24 years accounted for the 
remaining 15 percent.  
  
For persons 13 years of age and older (adults and adolescents), the median age at diagnosis in 2013 was 
39.5 years, more than three years above the five-year average of 36 years for the years from 2008 to 
2012. In 2013, adult/adolescent males had a median age at diagnosis of 40 years, somewhat older than 
the median of 38.5 years for females. 
   
There were 28 diagnoses in 2013 among non‐Hispanic black/African-American persons, the same as in 
2012, but five more than the five-year average of 23 from 2008 through 2012.  Thirteen (46 percent) 
were foreign-born. While non‐Hispanic blacks/African Americans made up almost three percent of 
Iowa’s population in 2013, they accounted for 23 percent of the new HIV diagnoses. This equates to 30.2 
diagnoses per 100,000 non‐Hispanic black/African-American persons. Hispanics were also 
overrepresented among persons diagnosed with HIV. While making up five percent of Iowa’s 
population, Hispanics accounted for seven percent of new HIV diagnoses in 2013. A total of nine 
Hispanic persons were diagnosed in 2013, equating to 5.5 per 100,000 Hispanic persons. Six (67 percent) 
of the Hispanics were foreign-born. While the numbers are small, there was a substantial increase in 
diagnoses among non-Hispanic Asians. Diagnoses increased from three in 2012 to eight in 2013, 
equating to 13.6 per 100,000 non-Hispanic Asian persons. All eight Asians were born in foreign 
countries. While making up two percent of Iowa’s population, non-Hispanic Asians were seven percent 
of new HIV diagnoses in 2013, the same proportion as Hispanics. Despite the racial and ethnic disparities 
noted above, the largest proportion of new diagnoses continued to be among non‐Hispanic white 
persons, who accounted for 61 percent of new HIV diagnoses in 2013. A total of 75 non‐Hispanic whites 
were diagnosed in 2013, equating to 2.8 per 100,000 non-Hispanic white persons. When the numbers of 
persons diagnosed per 100,000 population are compared, non‐Hispanic blacks/African Americans were 
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11 times more likely to have been diagnosed with HIV in 2013 than non‐Hispanic whites. Non-Hispanic 
Asians were almost five times more likely, and Hispanic persons two times more likely, to have been 
diagnosed with HIV in 2013 than non‐Hispanic white persons. Figure 12 shows the percentage 
distribution of new HIV diagnoses by race and ethnicity in 2013.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Men who have sex with men (MSM) remained the leading category for mode of exposure to HIV 
infection. Diagnoses among MSM in 2013 numbered 72, higher than the five-year average of 66 from 
2008 to 2012. In 2013, MSM accounted for 59 percent of all diagnoses, compared to a five‐year (2008 to 
2012) average of 57 percent. It is important to note that 12 (67 percent) of the 18 diagnoses in young 
men between the ages of 15 and 24 were among MSM.   
 
Numbers (and proportions) of other modes of HIV exposure in 2013 were as follows: injection drug use 
(IDU), eight (7 percent); men‐who‐have‐sex‐with-men and inject drugs (MSM/IDU), two (2 percent); 
heterosexual contact, 35 (29 percent); and no identified risk (NIR), five (4 percent). Experience has 
shown that while newly diagnosed persons may initially be reluctant to disclose risk to their health care 
provider or to health department staff, they become less reticent as they come to trust their providers.  
Such knowledge led to a successful reduction of NIR cases accomplished through follow-up calls to care 
providers. By the end of 2014, risk will have been ascertained for almost all of the remaining persons 
diagnosed in 2013. There were no reported infections passed from mother-to-child during pregnancy or 
labor and delivery in 2013. Such infections are termed “perinatal” or “vertical” transmission.   
 
Eighty‐two persons were diagnosed with AIDS in 2013, compared to 71 in 2012, and down from 91 (the 
highest number since 1996) in 2009. The 82 diagnoses in 2013 are higher than the average of 75 for the 
five years 2008 through 2012.  
  
HIV/AIDS prevalence continues to increase. As of December 31, 2013, there were 2,100 persons living 
with HIV or AIDS who were Iowa residents at time of diagnosis of HIV or AIDS, a prevalence of 68 per 
100,000 people. This compares to 2,023 persons living with HIV/AIDS on the same date in 2012, a 
prevalence of 66 per 100,000. Figure 13 depicts the upward trend in the estimated number of persons 
living with HIV or AIDS, as documented at the end of each calendar year. The top tier of the graph 
represents the estimated numbers of undiagnosed/unreported persons, based on the surveillance 
program’s estimate of the completeness of case reporting and on CDC’s estimate of the number of 
persons who are infected but have not been diagnosed. When the number of 2,100 is adjusted for 
underreporting (1 percent) of diagnosed HIV and AIDS and for CDC’s estimated percentage of 
undiagnosed infections (15.8 percent), there may have been as many as 2,524 Iowans living with HIV or 
AIDS at the end of 2013. 
Figure 12. Percentage distribution of Iowa HIV diagnoses by race and ethnicity, 2013 
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Hepatitis C 
Hepatitis C is the most common chronic blood-borne pathogen in the United States. According to the 
Centers for Disease Control and Prevention (CDC) there are an estimated 3.2 million people chronically 
infected with hepatitis C in the United States. According to the 2013 census population estimate for 
Iowa, there were 3,090,416 people residing in the state. CDC estimates that 1.3 to 1.9 percent of the 
state’s population, or 40,175 to 58,717 Iowans have potentially been infected with the hepatitis C virus.  
 
Hepatitis C data are collected using IDSS, the state’s web‐based reporting system, to allow for collection 
of risk information, test results, referral information, and data on whether immunizations were offered. 
Hepatitis C disease summary amended 9/25/2014 
Sexually Transmitted Diseases 
The Bureau of HIV, STD, and Hepatitis is responsible for tracking the incidence of sexually transmitted 
diseases, including chlamydia, gonorrhea, and syphilis. In addition to disease surveillance, IDPH supports 
targeted voluntary screening at 70 public sites throughout Iowa. IDPH also works with private health 
care providers to increase screening. 
 
IDPH provides free treatment to eligible individuals at public testing sites who test positive for 
chlamydia, gonorrhea, syphilis, or trichomoniasis. Sexual partners can be treated as well. In 2008, Iowa 
Code 139A was updated to allow for expedited partner therapy (EPT). This statute allows health care 
practitioners to give medications or prescriptions for the treatment of chlamydia or gonorrhea to their 
patients to give to exposed partners, particularly when the partner is unable or unwilling to come in to a 
clinic for examination. These medications may also be distributed to exposed partners via public health 
professionals. 
 
 
Figure 13. Estimated number of Iowans living with HIV or AIDS as of December 31 of each year, 1988-2013 
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Chlamydia 
Genitourinary infections caused by Chlamydia trachomatis are extremely common in some populations. 
In fact, chlamydial infections account for the greatest number of cases of any reportable disease in the 
United States and in Iowa. Diagnoses of chlamydia have increased steadily during the past few decades. 
The reasons for this increase are varied. One important reason is that testing technology has improved, 
allowing for more sensitive tests and more convenient ways to test. The use of nucleic acid amplification 
tests (NAATs) for the detection of Chlamydia trachomatis became widespread in Iowa in the mid-2000s. 
This method of detection is much more sensitive than the previously used method of cell culture. NAATs 
also permit the use of a greater variety of specimen types. Urine and vaginal specimens (which can be 
collected much less invasively than the traditional specimen types of cervical and urethral) can be used 
for NAATs. Because most chlamydial infections cause no symptoms, there is a large pool of undiagnosed 
chlamydia in certain populations. As testing methodology has improved and as screening has increased, 
the number of cases reported has also increased.  
 
In 2013, 11,006 cases of chlamydia were reported to IDPH (Figure 14). This corresponds to a rate of 361 
cases per 100,000 population. Iowa is lower than the U.S. average of 457 cases per 100,000 population. 
Both nationally and in Iowa, adolescents and young adults are the most impacted populations. In Iowa, 
69 percent of reported infections occurred in persons 15 to 29 years of age. 
 
Chlamydia also disproportionately affects people of color in Iowa. Although black, non-Hispanic persons 
accounted for three percent of the population in Iowa, 18 percent of chlamydial infections were 
diagnosed in this population. In fact, according to national data from CDC6, Iowa ranks number two in 
the nation for the rate of chlamydia among black, non-Hispanic populations in the US. 
 
Figure 14. Number of cases of chlamydia and gonorrhea by year, 2003-2013 
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Gonorrhea 
Nationally, the number of reported cases of gonorrhea has slowly increased over the past decade. 
Trends in Iowa had mirrored this until 2013, when the number of cases decreased. NAATs have been 
utilized for gonorrhea as they have been for chlamydia. The most widely used tests incorporate 
gonorrhea and chlamydia testing into a single specimen collection. Thus, patients are typically tested for 
both infections simultaneously.  
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In 2013, 1,473 cases of gonorrhea were reported to IDPH (Figure 14), which corresponds to 48 cases per 
100,000 population. This is well below the national average of 107.5 cases per 100,000 population. 
Gonorrhea has many similarities with chlamydia, chief of which is the population (i.e., 
adolescents/young adults) that it predominately affects. Fifty-five percent of reported cases in Iowa 
were among persons 15 to 24 years of age. Black, non-Hispanic persons are even more 
disproportionately affected by gonorrhea than they are by chlamydia in Iowa. Thirty-one percent of 
reported cases were among black persons (Figure 15). Iowa ranks number two for its rate of gonorrhea 
among black persons in the US. 
 
Antimicrobial resistance is of continuing concern with Neisseria gonorrhoeae. The only class of 
antimicrobials still effective in the treatment of gonococcal infection is the cephalosporins. 
Antimicrobials in other classes possess insufficient efficacy to cure the infection on their own. Current 
guidelines recommend dual therapy of ceftriaxone with azithromycin or doxycycline. 7 Dual therapy is 
recommended because individuals infected with gonorrhea are often co-infected with chlamydia. 
Furthermore, dual therapy likely slows the development of resistance to cephalosporins. Treatment 
failures with the last remaining effective oral cephalosporin have been confirmed in North America.8 It is 
anticipated that N. gonorrhoeae will develop resistance to all cephalosporins, at which time treatment 
will become much more difficult. Currently, no new antimicrobials are available to treat gonorrhea. 
Researchers are investigating the use of other drug combinations to cure gonococcal infections but it is 
unknown if and when new options will be available for population-wide clinical use. 
 
The significant disparities among black populations, the likelihood of further antimicrobial resistance by 
N. gonorrhoeae, and the steady number of cases make improving gonorrhea prevention a priority for 
IDPH and CDC. 
 
 
 
Syphilis 
Iowa is considered a low-morbidity state for syphilis; however, the number of reported cases has spiked 
in the last two years (Figure 16). In 2013, 226 cases of syphilis were reported to IDPH. Of these, 171 
were cases of early syphilis (primary, secondary, or early latent), which are of greatest concern to the 
public’s health because these are the infectious stages of the disease. In 2013, the rate of early syphilis 
in Iowa was 5.6 per 100,000 population; approximately 60 percent of the U.S. average of 9.6 per 
100,000 population. The preponderance of syphilis cases occurred in men. In terms of early syphilis, 91 
percent of cases were among men. Of these, the majority were men who have sex with men (MSM). Co-
Figure 15. Percentage of gonorrhea rates in Iowa by race, 2013 
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infection with HIV is a concern with this population, so concurrent testing for HIV is recommended for 
persons at risk for syphilis. 
 
The black population in Iowa is disproportionately affected by syphilis. Fourteen percent of reported 
cases of early syphilis were among this population, corresponding to a rate of 26 cases per 100,000 
population.
Elimination of syphilis from Iowa has proven difficult due to sporadic clusters of cases and the spread 
from other states. The more recent outbreak among Iowa’s MSM populations have complicated 
elimination efforts further, with challenging investigations and inadequate resources being significant 
contributing factors. IDPH follows up on every case of syphilis in Iowa and ensures that partner services 
and treatment are offered whenever they are appropriate and possible.  
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  Figure 16. Number of cases of syphilis by year 2003-2013 
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Summary of enteric diseases 
 
Campylobacteriosis 
The total number of Campylobacter cases reported in 2013 was 610. Campylobacteriosis incidence was 
20 cases for every 100,000 people in 2013. 
Campylobacteriosis activity typically peaks in early summer. Consumption of raw, undercooked meat, 
raw milk, contaminated water, and contact with infected animals are common sources of campylobacter 
infection.   
Figure 17. Campylobacteriosis cases versus 5 year average by month and year, 2011-2013 
 
 
Cryptosporidiosis 
Cryptosporidiosis activity in 2013 increased significantly from activity in 2012. There were 49.4 cases for 
every 100,000 Iowans in 2013, compared to 10.8 in 2012. Three separate outbreaks were investigated in 
June and July associated with recreational water exposure. In addition, an outbreak was investigated in 
October associated with the consumption of unpasteurized apple cider. These outbreaks accounted for 
the majority of the increase seen in the incidence of Cryptosporidiosis in 2013. 
Figure 18. Cryptosporidiosis cases versus 5 year average by month and year, 2011-2013 
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E. coli O157:H7 and other shiga-toxin producing strains 
The incidence of E. coli shiga-toxin cases in Iowa decreased slightly from 5.9 cases/100,000 Iowans in 
2012 to 5.6 cases/100,000 Iowans in 2013. There were 171 total cases reported in 2013. Most types of E. 
coli are harmless and live in the gut but some E. coli including O157:H7 can cause illness. E. coli is spread by 
a person eating or drinking food or water that was contaminated with feces from infected people or 
animals. Other sources of E. coli include consumption of raw milk, unpasteurized cider or other juices, or 
poorly cooked meat. 
Figure 19. E. coli O157:H7 and other shiga-toxin producing strains cases versus 5 year average by 
month and year, 2011-2013 
 
 
Giardiasis 
Giardiasis activity typically peaks in late summer or early fall. In 2013, there were 275 cases reported in 
Iowa. There were 9.0 cases for every 100,000 Iowans in 2013 compared to 8.2 cases for every 100,000 
Iowans the previous year.  
 
Figure 20. Giardiasis cases versus 5 year average by month and year, 2011-2013 
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Hepatitis A 
In 2013, 17 cases of hepatitis A were reported in Iowa. The three-year average from 2011 to 2013 was 
11 cases, which represents a 22 percent increase over the previous three-year average of nine cases. 
Cases ranged in age from 4 to 84 years of age, with three cases younger than 25. Fifty-three percent of 
cases were female. None of the cases were associated with outbreaks. 
 
Figure 21. Hepatitis A cases versus 5 year average by month and year, 2011-2013 
 
 
Listeriosis 
There were two cases of Listeria monocytogenes reported in 2013. Neither was associated with a 
national outbreak. 
 
Salmonellosis 
Salmonellosis incidence in 2013 decreased to 18.9 cases per 100,000 Iowans from 20.4 cases per 
100,000 Iowans in 2012. The total number of cases reported was 575. Local public health departments 
and IDPH investigated five Iowa-specific outbreaks: two associated with animal contact, one associated 
with a restaurant, one associated with a local festival and one with an unknown cause. Two national 
outbreaks involving contact with baby chicks were also investigated. 
Figure 22. Salmonellosis cases versus 5 year average by month and year, 2011-2013 
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  Shigellosis 
In 2013, 342 cases of Shigella were reported in Iowa,  an approximately 522 percent increase over the 
average number of cases for the past three years. The majority of cases were associated with a 
community-wide outbreak in western Iowa beginning in September and lasting through the end of the 
year. Of the outbreak cases, 63 percent were under the age of 10 and approximately 21 percent were in 
persons aged 20 to 49 years. This reflects that children and their parents or caretakers are at most risk 
of infection. 
Figure 23. Shigellosis cases versus 5 year average by month and year, 2011-2013 
Divisions of Acute Disease Prevention and Emergency Response, Environmental Health, and Behavioral Health 
29 
 
 
Summary of zoonotic and vectorborne diseases
Dengue fever 
In 2013, three cases of Dengue fever were reported to IDPH; one was female and the other two were 
males. Cases ranged from ages 13 to 38 with a median age of 32 years.  All three cases were acquired 
outside of the United States. 
 
Ehrlichiosis/Anaplasmosis 
There are at least three species of bacteria responsible for ehrlichiosis/anaplasmosis in the United 
States: Ehrlichia chaffeensis, Anaplasma phagocytophilum, and Ehrlichia ewingii. The clinical signs and 
symptoms of these infections are similar. 
In 2013, there were eight cases of ehrlichiosis/anaplasmosis reported to IDPH, an increase of two from 
the six cases reported in 2012. Cases ranged from ages 16 to 86 with a median age of 59 years and five 
cases were located in the northeast and two were in the southeast part of the state. 
Hantavirus 
There were no reports of hantavirus pulmonary syndrome (HPS) in Iowa in 2013. There have been nine 
cases of HPS reported in Iowa since the disease was first identified in 1993. Substantial rodent exposure 
was identified in most of these cases. 
 
Lyme disease 
Lyme disease is caused by Borrelia burgdorferi, is transmitted to humans by the bite of an infected tick, 
primarily the blacklegged tick. Symptoms of Lyme disease can include fever, headache, fatigue, and a 
“bull’s-eye” skin rash also known as erythema migrans. There were 247 cases of Lyme disease reported to 
IDPH in 2013, a 110.5 percent increase over the previous three-year average and the highest number of 
cases recorded since 2002 when reporting first began (Figure 24). The 2013 Iowa case rate for Lyme 
disease was 8.1 cases per 100,000 persons. Cases ranged from ages two to 85 with a median age of 39 
years. 
 
Figure 24. Confirmed and probable cases of Lyme disease reported to IDPH, 2002-2013 
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Malaria 
Twelve cases of malaria were identified in Iowa in 2013, an increase of six from the six cases reported in 
2012. Cases ranged from ages 3 to 70 with a median age of 36 years and all infections were acquired 
outside of the United States.  
 
Rabies, Animal 
In 2013, 12 cases of animal rabies were reported in Iowa, which is a significant decrease from 2012 
(Table 4). Rabies was identified most frequently in wildlife species, including six bats and four skunks. 
Two cases were diagnosed in cows.  
 
During 2013, 1420 animals in Iowa were tested for 
rabies and 12 were confirmed positive (0.85 
percent).The percent positive varies greatly by 
species, see Table 3. It is important to note that this 
data is greatly influenced by the number of animals 
tested. Many animals are tested because they have 
contact with humans or domestic animals and they exhibit unusual behavior or clinical signs making 
them more likely to be infected with the rabies virus. For these reasons, the percentages should not be 
considered representative of the true distribution of disease within the animal population in Iowa. 
 
There are two rabies strains that commonly circulate in Iowa (bat and skunk), and many different 
species can be infected with these strains. In animal samples that are strongly positive for rabies, the 
State Hygienic Laboratory (SHL) can differentiate the strain of rabies virus that infected the animal (the 
strain typing procedure is only effective in samples that are strongly positive). In 2013, SHL was able to 
identify the rabies strain in seven of the positive rabies cases; bat strain rabies was identified in four bats 
and skunk strain rabies was identified in two skunks and one cow. For more information about rabies, 
visit https://idph.iowa.gov/rabies . 
 
Table 4. Number of animals positive for rabies by species and by year, 2003-2013 
Species 2003 2004 2005 2006 2007 2008 2009 2010 2011 
 
2012 
 
2013 
Bat 47 47 60 28 13 11 11 10 12 17 6 
Skunk 38 28 33 13 5 7 13 13 7 9 4 
Cat 8 11 5 7 7 9 3 1 3 1 0 
Cow 3 10 7 4 0 1 5 1 3 4 2 
Dog 6 3 2 2 5 1 2 1 0 0 0 
Horse 3 0 1 3 1 0 0 0 0 0 0 
Fox 0 1 0 0 0 0 0 1 0 0 0 
Squirrel 0 0 0 0 0 0 1 0 0 0 0 
Badger 1 0 0 0 0 0 0 0 0 0 0 
Total 106 100 108 57 31 29 35 27 25 
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Rabies, Human 
Iowa’s most recent human rabies case occurred in 2002 and was caused by bat strain rabies. Prior to 
that, the last reported human case in Iowa occurred in 1951.  
Table 3. Number of animals positive for rabies 
virus by species, 2013 
Species Positive Total Tested % Positive 
    Cow 2 68 2.94% 
    Bat 4 480 0.83% 
Skunk 6 10 60.00% 
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While the exact number of people who receive rabies post-exposure prophylaxis each year in the United 
States is unknown, it is estimated to be about 40,000 people. Based upon Iowa’s population, it is 
estimated that approximately 400 Iowans receive rabies preventive treatment each year.  
 
Rocky Mountain Spotted Fever (RMSF) 
In 2013, eight cases of Rocky Mountain spotted fever (RMSF) were reported in Iowa. American dog ticks 
are carriers of Rickettsia rickettsii, the bacteria that causes RMSF. The American dog tick is the most 
common species of tick in Iowa and can be found in every county in the state. The tick is most active late 
March through August. Iowa RMSF cases in 2013 had symptom onset dates from March to September. 
Cases ranged from ages 14 to 83, with a median age of 55. Four cases were female and four were male. 
Three of the eight cases were hospitalized. 
 
West Nile Virus 
There were 44 human cases of West Nile virus reported to IDPH in 2013. Thirty-four of the 44 cases 
were hospitalized, and no deaths were reported. Cases ranged from age 18 to 83, with a median age of 
55. Twenty-three cases were male and 21 were female. The highest numbers of cases were reported in 
the northwest region of the state. For more information about this disease, visit 
https://idph.iowa.gov/cade/disease-information/west-nile-virus. 
 
Table 5. Iowa West Nile virus activity by species and outcome, 2003-2013
  2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Human cases 147 23 37 37 30 5 5 9 9 31 44 
Human deaths 6 2 2 0 3 1 0 2 0 0 0 
Sentinel chickens 15 9 19 18 18 3 6 14 14 17 15 
Mosquito (pools) 27 0 7 15 5 5 9 7 5 14 66 
Horses 96 18 15 12 10 4 3 2 1 35 11 
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Summary of Rare and Unusual Diseases 
 
Toxic Shock Syndrome 
There was one case of Toxic Shock Syndrome reported to IDPH in 2013, which occurred in a female child 
(0-17 years of age).    
 
Tularemia 
There were four case of tularemia reported to IDPH in 2013. All of the cases were males and cases 
ranged from ages eight to 66, with a median age of 19.  
 
Hansen’s disease (Leprosy) 
There was one case of Hansen’s disease reported to IDPH in 2013, which occurred in a male child (0-17 
years of age). 
 
Tetanus 
There was one case of tetanus reported to IDPH in 2013, which occurred in a male child (0-17 years of 
age). 
 
There were no cases of human illness reported for the following diseases: 
Hepatitis E 
Psittacosis 
Yellow Fever 
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Summary of environmental health conditions 
 
Carbon Monoxide (CO) Poisoning Surveillance 
According to the CDC, more than 400 people in the US die from unintentional CO poisoning each year; 
additionally, more than 20,000 visit the emergency room and more than 4,000 are hospitalized due to 
CO poisoning. Fatalities are highest among Americans 65 and older. IDPH collects reports of CO 
poisoning and CO exposure from health care providers and facilities, and the Iowa Statewide Poison 
Control Center. CO poisoning is defined in Iowa as: 
 A blood carbon monoxide level equal to or greater than 10 percent carboxyhemoglobin or its 
equivalent with a breath analyzer test; or 
 A clinical diagnosis of carbon monoxide poisoning regardless of any test result.  
Information collected includes basic demographics (age, gender, county of residence), diagnosis, blood 
carboxyhemoglobin test results, exposure (circumstance, source, location), and severity of health 
impact. Reports are reviewed to identify clusters and possible occupational exposures for further  
investigation and intervention. 
 
In 2013, there was one reported death from CO 
exposure in Iowa. Sixty-one individual reports of 
CO poisoning were received by IDPH. 
 
 
 
 
 
 
Fatal – Patient died due to Carbon monoxide poisoning 
Major – Patient experienced major symptoms (loss of consciousness, long-term complications) 
Moderate – Patient experienced moderate symptoms such as nausea, vomiting, confusion 
Minor – Patient experienced minor symptoms such as headache, dizziness 
 
 
 
 
 
 
Table 6. Gender of cases with carbon monoxide 
poisoning meeting case definition, 2013 
 Number of cases 
Male 34 
Female 27 
Total Cases 61 
 
 Figure 25. Severity of health impact among case patients with CO poisoning, 2013 
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Vehicles include automobiles and other fuel-powered recreational vehicles (e.g., boats, four-wheelers, Zamboni Ice Resurfacing machines, etc.). 
Fixed appliances include fuel-burning equipment that is typically stationary (e.g., furnaces, gas water heaters, gas stoves or fireplaces). 
Mobile appliances include generators, space heaters, and other small power equipment (e.g., power washers, lawn mowers, chainsaws, etc.) 
Methemoglobinemia 
Methemoglobinemia is a blood disorder caused when nitrite interacts with the hemoglobin in red blood 
cells, reducing the ability to carry sufficient oxygen to individual body cells. Infants under six months of 
age are the primary population at risk, and the condition is also known as ‘Blue Baby Syndrome’. Sources 
of nitrite include nitrate in drinking water, from preservatives in food, specific drugs, and other sources. 
 
In 2013, there were four cases of methemoglobinemia reported in Iowa. There were no cases reported 
in an infant. 
 
Heavy Metal Poisoning (Non-Lead) 
IDPH conducts surveillance for three other heavy metals in addition to lead: arsenic, cadmium, and 
mercury. Cases of poisoning from these three heavy metals are rare in Iowa and those that do  are most 
often related to industrial or hobby/small market work in industries that use these metals. Outside of 
industrial use, the possibility of arsenic contamination of moonshine, herbal preparations, and 
nutritional supplements also must be considered as a source of exposure. Other potential sources of 
mercury exposure include consumption of large amounts of contaminated fish and seafood, or from 
broken thermometers, barometers, fluorescent light bulbs, or electrical switches. In 2013, there was one 
case of arsenic poisoning, and no cases of cadmium or mercury poisoning reported. 
Childhood lead poisoning 
Lead has adverse effects on nearly all organ systems in the body. It is especially harmful to the 
developing brains and nervous systems of children under the age of 6. At very high blood lead levels, 
children can have severe brain damage or even die. Recent research suggests that there is no level of 
lead exposure at which adverse health and developmental effects do not occur. At blood lead levels as 
low as 1 microgram per deciliter (μg/dL), children’s intelligence, hearing, and growth are affected. This 
damage can be minimized if a child’s lead exposure is reduced; however, the damage cannot be 
reversed. The Centers for Disease Control and Prevention recommends that public health actions be 
initiated at blood lead levels above 5 µg/dL, and has a goal to eliminate blood lead levels greater than or 
equal to 10 µg/dL in children. 
 
Iowa's children are most commonly poisoned by lead‐based paint found in homes built before 1950. 
Lead‐based paint in a home becomes a lead hazard as it deteriorates and lead‐based paint chips end up 
on the floors and in window wells throughout the home, as well as in the soil around the exterior of a 
Figure 26. Sources of exposure among case patients with CO poisoning, 2013  
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home. Since 2008, Iowa law has required that all children have proof of a blood lead test when enrolling 
in kindergarten. Currently, the percentage of children in Iowa receiving at least one blood lead test by 
kindergarten is above 98 percent. 
 
There are two types of specimens for blood lead tests completed in Iowa. These specimen types include 
a finger or heel stick (capillary test) and blood drawn from a vein (venous test). The venous test is more 
accurate, and is required to confirm the result of an abnormal capillary test result of 10 µg/dL or greater.  
There were 67,772 children under the age of 6 in Iowa that had their blood lead tested for lead in 2013.  
Of these 67,772 children tested in Iowa, 67,217 (99.18 percent) had blood lead levels below the 10 
µg/dL level. There were 321 children with confirmed elevated blood lead levels in 2013. A confirmed 
elevated blood lead level is defined as 1) any venous blood level test result greater than or equal to 10 
µg/dL , or 2) a set of two capillary blood lead test results greater than or equal to 10 μg/dL conducted 
less than 12 weeks apart. There were 234 children with unconfirmed elevated blood lead levels in 2013.  
An unconfirmed elevated blood lead level is any capillary blood lead test result greater than or equal to 
10 μg/dL that is not confirmed by a follow-up capillary or venous blood lead test within 12 weeks. More 
detailed information of the confirmed blood lead tests completed in children during 2013 is included in 
Table 7. 
 
Table 7.  Children with Confirmed Elevated Blood Lead Levels by Highest Confirmed Level: 
Blood Lead Level 
Range 
Number of Children 
Confirmed Elevated 
Percent of Children with Confirmed Elevated in Range 
(Number of Children Confirmed Elevated / 321 x 100) 
10-14 μg/dL 141 43.93 
15-19 μg/dL 80 24.92 
20-24 μg/dL 47 14.64 
25-44 μg/dL 47 14.64 
45-69 μg/dL 5 1.56 
>70 μg/dL 1 0.31 
 
ADULT LEAD POISONING 
A total of 5,866 blood lead level (BLL) test results on 3,173 Iowans were recorded by the Iowa Adult Blood 
Lead Epidemiology and Surveillance (ABLES) program for adults 16 years or older as of the date of collection 
with a residence in Iowa tested in calendar year 2013. All blood lead test results for Iowa residents are 
reportable to IDPH under Iowa Administrative Code 641, Chapter 1. Additional information is available at 
https://idph.iowa.gov/lpp/what-is-lead-poisoning . 
 
Blood lead tests of 10 micrograms per deciliter (µg/dL) or higher are currently defined as an elevated blood 
lead level (EBL) for an adult. Based on the highest BLL for each Iowa adult tested in 2013, there were 856 
people (27 percent of those tested) who had blood lead levels of 10 µg/dL or higher; 19 people with levels 40 
µg/dL or higher, 183 people with levels 25-39 µg/dL, and 654 people with levels 10-24 µg/dL. The remaining 
Iowa adults tested (2,317, 73 percent) had results less than 10 µg/dL, with an average BLL less than 3 µg/dL. 
 
Females accounted for 13 percent (111) of the 856 EBLs in 2013. This is an increase from 2012 when 11 
percent (92) of the 2012 EBLs were female. The blood lead levels for EBL females ranged from 10-73 µg/dL 
with an average blood lead level of 20 µg/dL. Lead exposure to women during pregnancy poses increased 
health risks for unborn babies and may impact the ability to carry the pregnancy to term. Women of child-
bearing age (16-44 years of age i.e., those born in 1969 or later) accounted for 43 of the 111 female cases (39 
percent), an increase from 28 females (30 percent) in 2012.The 2013 data also showed an increase in EBL 
females 35 years of age or younger, with 24 or 21.6 percent of the 111 EBLS women in this age range 
compared to 11 (12 percent of 92) in 2012. It is unknown if any of these women were pregnant at the time of 
their exposure. Most of the women with EBLs (107 of 111, 96 percent) had work-related lead exposure, 
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almost entirely in battery manufacturing.  
 
Prior exposure to lead from Ayurvedic products purchased overseas was known as the reason for repeat 
testing of 18 Iowans in 2013, with nine individuals still exhibiting a persistent elevated blood lead level since 
diagnosis in 2011. Current blood lead levels ranged from 11-23 µg/dL. 
 
Lead exposure due to the use of firearms, making or reloading of ammunition, or making fishing jigs was 
identified in 15 Iowans in 2013. Their EBLs ranged from 10 to 57 µg/dL, with an average BLL of 20 µg/dL. While 
the 2013 data for this type of exposure shows an increase of two persons compared to 2012, the blood lead 
level range and average BLL were much lower (2012: EBL range 10 to 91 µg/dL, with a mean of 28 µg/dL). 
Many of the same people had exposures in past years, and have been provided with information regarding 
options for lowering their exposure.    
 
Iowa’s high risk industries in 2013 remain consistent with data from previous years, with the majority (770 of 
856 or 90 percent) of EBL adults working in manufacturing plants that use lead or metal products that contain 
lead. Ten employers accounted for 786 workers with EBLs or almost 92 percent of the EBL Iowans in 2013.  
These workers are also the most likely to be tested for lead exposure because of regulatory oversight or 
concerns about the risk of exposure in a fixed worksite environment. The second highest industry group was 
construction with 23 of 856 or 2.7 percent, which includes industrial, commercial, and residential 
construction, painting, maintenance, and renovation projects. It is known that many workers in construction 
are not routinely tested for lead exposure. Other work-related cases in 2013 included exposures from 
electronic and scrap metal recycling, materials wholesalers and retailers, automotive or radiator repair, 
leaded glass workers and installers, transportation maintenance shops, and a variety of other work types. 
Additional workers, especially those working for smaller companies or those who are self-employed, may 
have lead exposure but were never tested during the 2013.There were 23 known exposures (2.7 percent) 
from hobby or non-work situations, including the highest exposure of the year (EBL of 73 µg/dL). A total of 
seven exposures did not have a source of exposure identified, although 2 were known to be work-related.   
 
Table 8. Iowa adult blood lead test results, 2010-2013 and changes from 2012-2013 
 Number of Iowa Adults Tested  
by Highest BLL/Year 
Percent of all Iowa Adults 
Tested by BLL Range for Year 
IA ABLES DATA 2013 
Prior 3-
yr Ave 
2012 2011 2010 
2013 change 
in numbers 
from 2012 
2012 2011 2010 
BLL 40 µg/dL or higher 19 21 22 37 14 -3 0.7% 1.1% 0.5% 
BLL 25-39 µg/dL 183 178 174 203 159 9 5.8% 6.5% 5.5% 
BLL 10-24 µg/dL 654 555 622 592 563 32 20.7% 18.8% 19.4% 
BLL 0-9 µg/dL 2317 2068 2187 2323 2169 130 72.8% 73.6% 74.7% 
All BLL 10+ (Total EBLS) 856 754 818 832 736 38 27.2% 26.4% 25.3% 
Total Individuals Tested 3173 2822 3005 3155 2905 168     
Adults:  Persons 16 years of age or older as of date of blood test. 
Iowa Adult Data:  Test results for persons with an Iowa residential address as of date of blood test.  Blood lead test reports received without 
address data or with a residential address outside of Iowa are not included in this report.  Report reflects data in database as of May 30, 2014.  
Later data entries are not included at this time. 
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Figure 27. Number of adults by year with elevated blood lead test results, 1998-2013 
 
 
 
TRAUMATIC WORK-RELATED FATALITIES SURVEILLANCE  
The IDPH Occupational Health and Safety Surveillance Program (OHSSP) includes the Iowa Fatality 
Assessment and Control Evaluation (FACE) program, with work subcontracted to the University of Iowa 
College of Public Health and collaboration with the Iowa Office of the State Medical Examiner. The FACE 
program receives funding from the National Institute of Occupational Safety and Health (NIOSH). 
 
Iowa FACE has identified 60 work‐related fatalities for 2013 (provisional data). Transportation incidents 
of all types were the largest single type of event causing work‐related fatalities in Iowa (29 of 60; 48 
percent) including 15 roadway fatalities and 11 off-roadway fatalities. Agriculturally-related (ag-related) 
activities involved 23 of the 60 deaths (38 percent), including 11 (38 percent) of the transportation 
incidents. Of the 11 ag-related transportation incidents, four involved tractors, two involved ATVs or 4-
wheel utility vehicles, and two involved pedestrians struck by a moving vehicle or equipment. Ages for 
work-related traumatic fatalities ranged from 16 to 81 years of age with a median age of 50. Females 
accounted for 3 percent of the known work-related deaths.   
 
For fatalities to be included as a FACE “case,” the incident causing the work‐related death has to occur in 
Iowa (resident or non‐resident), and be traumatic in nature. Deaths that occur while commuting to or 
from work do not qualify. Iowa workers killed while working out of state are not included.  
 
Some potential cases may not be identified due to lack of surveillance data, especially for individuals 
killed in motor vehicle crashes when it is unknown that the person was traveling as part of their job 
duties (other than commuting). Some cases are not identified until months after the incident. Case 
definition may also vary between agencies involved in worker surveillance. For these reasons, total case 
numbers may differ between those reported by other programs, such as the US Bureau of Labor 
Statistics Census of Fatal Occupational Injuries (CFOI) or the Iowa Worker Memorial Day observance. 
Additional information can be found at www.public-health.uiowa.edu/face/ and 
https://idph.iowa.gov/lpp/occupational-health .  
 
 
 
 
Figure 28. Iowa FACE work-related death, 2001-2013    
 
* Updated data 
**Preliminary data 
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 2013 Iowa summary of reported outbreak investigations 
 
Table 9. Norovirus/Suspect Norovirus Outbreaks, 2013 
Type Nature of  
Episode 
Event/Place County Month Number 
Affected/Number 
Exposed (if 
known) 
Agent Involved, Number of  
Positive Tests, if known 
1. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Conference Dallas January 31/120 Norovirus - 3 
2. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Restaurant Jefferson January 10 Norovirus - 1 
3. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
School Linn February 30 Norovirus - 3 
4. Norovirus 
 
 
Diarrhea, 
Vomiting, 
Chills 
Hospital Johnson February 8/9 Norovirus - 2 
5. Norovirus 
 
 
Diarrhea, 
Vomiting, 
Nausea 
Restaurant Johnson February 10 Norovirus -2  
6. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Hospital Emmet February 20 Norovirus -2 
7. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Restaurant Woodbury February 2/2 Suspect Norovirus 
8. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Long-Term Care Cerro Gordo February 60/85 Norovirus - 3 
9. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Long-Term Care Buchanan February 49 Norovirus -3 
10. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Elementary 
School 
Scott February 157/596 Norovirus - 2 
11. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Hospital Poweshiek February 9 Norovirus -2 
Iowa Department of Public Health 
 40 
12. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Restaurant Woodbury March 5/5 Suspect Norovirus 
13. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Child Care Dallas March 8 Suspect Norovirus 
14. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Hospital Jasper March 8 Norovirus - 5 
15. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Conference Out of State March 16/25 Norovirus – 3  
Campylobacter - 1 
16. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Family Gathering Black Hawk March 6/10 Norovirus - 1 
17. Norovirus 
 
Diarrhea, 
Vomiting, 
Nausea 
Hospital Buena Vista March 10 Norovirus - 2 
18. Norovirus Diarrhea, 
Vomiting, 
Nausea 
Long-Term Care Delaware March/Apri
l 
16/60 Suspect Norovirus 
19. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Long-Term Care Delaware April 26/60 Norovirus - 4 
20. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Retirement 
Community 
Dubuque April 13 Suspect Norovirus 
21. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Restaurant Clarke April 4/5 Suspect Norovirus 
22. Norovirus 
 
Diarrhea, 
Vomiting, 
Chills 
Wedding Story April 6/100 Suspect Norovirus 
23. Norovirus Vomiting, 
Diarrhea 
Long-term Care 
Facility 
Grundy April 11 Suspect Norovirus 
24. Norovirus 
 
Diarrhea, 
Vomiting, 
Nausea 
Elementary 
School 
Woodbury May 50/500 Norovirus - 6 
25. Norovirus 
 
Diarrhea, 
Vomiting, 
Nausea 
Elementary 
School 
Butler May 34 Suspect Norovirus 
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26. Norovirus Diarrhea, Abd 
Cramps, 
Vomiting 
Long-term Care 
Facility 
Tama October 20/56 Suspect Norovirus 
27. Norovirus Diarrhea, 
Vomiting, Abd 
Cramps 
Elementary 
School 
Linn November 103/425 Norovirus - 3 
28. Norovirus Diarrhea, 
Vomiting, Abd 
Cramps 
Wedding Delaware/ 
Linn/Johnson 
November 30/150 Norovirus - 7 
29. Norovirus Vomiting, 
Diarrhea, Abd 
Cramping 
High School Hancock September 30/300 Suspect Norovirus 
30. Norovirus Diarrhea, 
Vomiting 
Elementary 
School 
Lyon Nov/Dec 27 Suspect Norovirus 
31. Norovirus Diarrhea, 
Vomiting 
Elementary 
School 
Webster December 36/358 Suspect Norovirus 
32. Norovirus Diarrhea, 
Vomiting 
Family Gathering Dubuque December 12/20 Suspect Norovirus 
33. Norovirus Diarrhea, 
Vomiting 
Restaurant Linn December 9/12 Suspect Norovirus 
34. Norovirus Diarrhea, 
Vomiting, 
Nausea 
Restaurant Polk December 3/5 Suspect Norovirus 
35. Norovirus Nausea, 
Vomiting 
School Linn December 26/193 Norovirus - 1 
36. Norovirus Vomiting, 
Diarrhea 
Inpatient Unit Black Hawk December 10/20 Norovirus - 1 
37. Norovirus Diarrhea, 
Vomiting, 
Nausea 
Long-Term Care Scott December 47/136 Norovirus - 3 
38. Norovirus Diarrhea, 
Vomiting 
Funeral Luncheon Lyon December 25/175 Norovirus - 2 
39. Norovirus Diarrhea, 
Vomiting, 
Cramps 
Restaurant Woodbury December 7/13 Norovirus - 2 
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Table 10. Non-Norovirus, Non-Foodborne or Unknown Cause Outbreaks, 2013 
Type Nature of  Episode Event/Place County Month Number 
Affected/Numbe
r Exposed (if 
known) 
Vehicle of  
Transmission 
Agent Involved, Number of  
Positive Tests, if known 
40. Person-to-
Person 
 
Vomiting, 
Fever 
Long-Term Care Clinton January 38/70 Person-to-Person 
 
Unknown 
41. Person-to-
Person 
  
Diarrhea, 
Vomiting, 
Chills 
Long-Term Care Madison February 11/60 Person-to-Person 
 
Unknown 
42. Vaccine 
Preventable 
Diarrhea, 
Vomiting, 
Fever 
Long-Term Care Johnson February 4 Person-to-Person Suspect Influenza 
43. Person-to-
Person 
 
Diarrhea, 
Vomiting, 
Nausea 
 
School Pottawattami
e 
April 2/16 Waterborne 
 
Vibrio Cholera - 1 
44. Animal-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Home/Farm Store Multi-county April 6 Animal-to-Person Salmonella Typhimurium 
1304MLJPX-1 
45. Animal-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Home/Farm Store Multi-county April 5 Animal-to-Person Salmonella Infantis 
1306MLJFX-3 
46. Water-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Public Pool Webster July 7 + 1 epi-link Water-to-Person Cryptosporidium 
47. Water-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Public Pool Polk July 2 + 3 epi-link Water-to-Person Cryptosporidium 
48. Water-to-
Person 
 
Vomiting, 
Diarrhea, 
Fever 
Splash Pad Polk June 5 + 5 epi-link Water-to-Person Cryptosporidium 
49. Animal-to-
Person  
Vomiting, 
Diarrhea, Fever 
Child Care Marion September 4/15 Person-to-Person Cryptosporidium 
50. Person-to-
Person  
Diarrhea, Abd 
Cramping 
Religious Retreat Dallas October 3/16 Person-to-Person Cryptosporidium - 2 
51. Person-to-
Person  
Diarrhea, Abd 
Cramps 
 
Community-wide Woodbury Sept-March 332 Person-to-Person Shigella - 214 
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52. Person-to-
Person  
Vomiting, 
Diarrhea, Nausea 
Long-term Care 
Facility 
Muscatine December 16/77 Person-to-Person Shigella - 1 
 
Table 11. Foodborne Outbreaks, 2013 
Type  Nature 
of  Episode 
Event/Place Location of 
Food 
Preparation 
Location of Food 
Consumption 
County Month Number 
Affected/Numbe
r Exposed (if 
known) 
Food Vehicle 
of 
Transmission 
Agent Involved 
Number of Positive 
Tests, if known 
53.  Foodborne Vomiting Catered Meal Caterer Childcare Black 
Hawk 
January 15/54 Chicken 
Tetrazzini 
Staphylococcus 
aureus toxin - 3 
54.  Foodborne Diarrhea, 
Fever, 
Vomiting 
 
Restaurant Restaurant Restaurant Multi-
county 
March 3 Unknown Salmonella 
Typhimurium - 2 
55. Foodborne Diarrhea, 
Fatigue, 
Anorexia, 
Wt. loss 
Restaurant Restaurant Restaurant Multi-
County 
June 136 Pre-packaged 
Salad Mix 
Cyclospora – 136 
56. Foodborne Diarrhea, 
Nausea, 
Vomiting 
 
Unknown Unknown Unknown Multi-
County 
June/July 31 Unknown Salmonella 
Enteriditis – 31 
57. Foodborne Diarrhea, 
Nausea, 
Fever 
Festival Church Festival Henry Aug/Sept 4 Unknown Salmonella  
Hartford - 4 
58. Foodborne Diarrhea, 
Nausea 
Private 
Residence 
Private 
Residence 
Private 
Residence 
Johnson Oct 10 Unpasteurized 
Apple Cider 
Cryptosporidium - 3 
59. Foodborne Diarrhea, 
Cramps 
Workplace Unknown Workplace Van Buren March 3/10 Unknown Salmonella 
Typhimurium – 1; 
Salmonella  
Subsp. I - 1 
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Table 12. Cases and rates per 100,000 population for 2013 by age group 
 
0 to 4 5 to 19 20 to 29 30 to 39 40 to 64 >64 Unk Total 
Disease Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnoses) 0 0.0 4 0.6 14 3.4 22 6.1 38 3.8 4 0.9 0 82 2.7 
Botulism 3 1.5 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 0 3 0.1 
Campylobacteriosis 81 40.1 111 17.9 98 23.8 83 22.9 186 18.6 51 11.3 0 610 20.0 
Chlamydia 9 4.5 2641 427.1 6925 1684.1 1162 321.1 265 26.5 4 0.9 0 11006 361.3 
  Cryptosporidiosis 283 140.0 419 67.8 276 67.1 269 74.3 199 19.9 59 13.0 0 1505 49.4 
Dengue fever 0 0.0 1 0.2 0 0.0 2 0.6 0 0.0 0 0.0 0 3 0.1 
E. coli/shg toxin producing 42 20.8 54 8.7 15 3.6 14 3.9 22 2.2 24 5.3 0 171 5.6 
Ehrlichiosis/anaplasmosis 0 0.0 2 0.3 0 0.0 0 0.0 3 0.3 3 0.7 0 8 0.3 
Giardiasis 52 25.7 60 9.7 33 8.0 36 9.9 69 6.9 25 5.5 0 275 9.0 
Gonorrhea 0 0.0 266 43.0 854 207.7 224 61.9 129 12.9 0 0.0 0 1473 48.4 
Hemolytic uremic syndrome 4 2.0 1 0.2 0 0.0 0 0.0 1 0.1 0 0.0 0 6 0.2 
Hepatitis A 1 0.5 2 0.3 2 0.5 1 0.3 8 0.8 3 0.7 0 17 0.6 
Hepatitis B, acute 0 0.0 0 0.0 3 0.7 2 0.6 4 0.4 2 0.4 0 11 0.4 
Hepatitis B, chronic 2 1.0 24 3.9 75 18.2 66 18.2 94 9.4 15 3.3 0 276 9.1 
HIV (diagnoses) 0 0.0 6 1.0 27 6.6 28 7.7 56 5.6 5 1.1 0 122 4.0 
Legionellosis 0 0.0 0 0.0 0 0.0 2 0.6 4 0.4 5 1.1 0 11 0.4 
Listeriosis 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 2 0.4 0 2 0.1 
Lyme disease 12 5.9 63 10.2 24 5.8 26 7.2 85 8.5 37 8.2 0 247 8.1 
Malaria 2 1.0 2 0.3 1 0.2 3 0.8 3 0.3 1 0.2 0 12 0.4 
Meningococcal Inv. Disease 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 1 0.2 0 1 0.0 
Mumps 1 0.5 1 0.2 1 0.2 0 0.0 0 0.0 0 0.0 0 3 0.1 
Pertussis (whooping cough) 74 36.6 179 28.9 13 3.2 10 2.8 24 2.4 8 1.8 0 308 10.1 
Q fever 0 0.0 0 0.0 0 0.0 0 0.0 3 0.3 1 0.2 0 4 0.1 
Rocky Mountain spotted fever 0 0.0 1 0.2 0 0.0 2 0.6 2 0.2 3 0.7 0 8 0.3 
  Salmonellosis 90 44.5 102 16.5 75 18.2 60 16.6 164 16.4 84 18.5 0 575 18.9 
  Shigellosis 97 48.0 142 23.0 32 7.8 27 7.5 34 3.4 10 2.2 0 342 11.2 
Syphilis 0 0.0 9 1.5 67 16.3 55 15.2 86 8.6 9 2.0 0 226 7.4 
Tuberculosis 0 0.0 4 0.6 12 2.9 11 3.0 13 1.3 7 1.5 0 47 1.5 
Typhoid fever 0 0.0 0 0.0 1 0.2 0 0.0 0 0.0 0 0.0 0 1 0.0 
West Nile virus   0 0.0 1 0.2 1 0.2 4 1.1 24 2.4 14 3.1 0 44 1.4 
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Table 13. Cases and rates per 100,000 population for 2013 by sex, Iowa 
  Sex 
 
Female Male Unk Total 
Disease Cases Rate Cases Rate Cases Cases Rate 
AIDS (diagnosis) 22 1.4 60 4.0 0 82 2.7 
Botulism 0 0.0 3 0.2 0 3 0.1 
Campylobacteriosis 260 16.9 349 23.1 1 610 20.0 
Chlamydia 7921 515.0 3085 204.5 0 11006 361.3 
Cryptosporidiosis 836 54.4 669 44.4 0 1505 49.4 
Dengue fever 1 0.1 2 0.1 0 3 0.1 
E. coli and other shiga-toxin producing  74 4.8 96 6.4 1 171 5.6 
Ehrlichiosis/anaplasmosis  3 0.2 5 0.3 0 8 0.3 
Giardiasis 124 8.1 149 9.9 2 275 9.0 
Gonorrhea 806 52.4 667 44.2 0 1473 48.4 
Hemolytic uremic syndrome 2 0.1 4 0.3 0 6 0.2 
Hepatitis A 9 0.6 8 0.5 0 17 0.6 
Hepatitis B, acute 7 0.5 4 0.3 0 11 0.4 
Hepatitis B, chronic 124 8.1 152 10.1 0 276 9.1 
HIV (diagnoses) 34 2.2 88 5.8 0 122 4.0 
Legionellosis 2 0.1 9 0.6 0 11 0.4 
Listeriosis 1 0.1 1 0.1 0 2 0.1 
Lyme disease 108 7.0 139 9.2 0 247 8.1 
Malaria 4 0.3 8 0.5 0 12 0.4 
Meningococcal invasive disease 1 0.1 0 0.0 0 1 0.0 
Mumps 1 0.1 2 0.1 0 3 0.1 
Pertussis (whooping cough) 174 11.3 133 8.8 1 308 10.1 
Q fever 1 0.1 3 0.2 0 4 0.1 
Rocky Mountain spotted fever 4 0.3 4 0.3 0 8 0.3 
Salmonellosis 309 20.1 266 17.6 0 575 18.9 
Shigellosis 179 11.6 162 10.7 1 342 11.2 
Syphilis 29 1.9 197 13.1 0 226 7.4 
Tuberculosis 19 1.2 28 1.9 0 47 1.5 
Typhoid fever 0 0.0 1 0.1 0 1 0.0 
West Nile virus 21 1.4 23 1.5 0 44 1.4 
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Table 14. Notifiable diseases by year, 1993-2013 
Notifiable 
diseases 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
 
2008 2009 2010 2011 2012 2013 
AIDS (diagnosis) 103 110 104 97 75 60 77 80 80 75 75 70 78 79 68 66 91 73 73 71 82 
Anthrax                                           
  Botulism             1         1   1 1 1 0       3 
  Brucellosis  2 1 2 4 4 1 6   2 1     1 2 0 2 2   1 0 2 
Campylobacteriosis 292 280 274 339 425 455 467 499 467 427 458 559 537 449 524 591 552 751 747 534 610 
Chlamydia 5214 5412 5088 4165 4906 5173 5511 5989 5716 6241 6462 6958 7390 8399 8643 9372 9406 10542 10928 11139 11006 
Cholera   1         1                           1 
  Cryptosporidiosis   71 21 75 71 66 56 77 82 49 122 90 122 230 610 284 232 397 364 328 1505 
  Cyclospora       3 1 3     1               1   1 0 148 
  Dengue Fever                         1 1 6 5 2 2 5 2 3 
 Diphtheria                                           
  Ehrlichiosis                   1 1   4 7 7 7 8 2 8 6 8 
  Encephalitis 
(arboviral except 
WNV) 4 1 13 19 3 3 3 4 3 3   2   1               
E. coli/other shiga-
toxin producing 27 54 64 123 114 93 114 180 81 122 103 124 108 161 185 208 163 173 189 181 171 
Hemolytic uremic 
syndrome*                                     13 10 6 
  Giardiasis 340 339 391 410 358 429 377 420 345 315 277 301 280 302 301 326 291 284 270 251 275 
Gonorrhea 1824 1645 1723 1144 1309 1615 1365 1394 1424 1496 1544 1249 1606 1981 1928 1700 1658 1804 1966 1982 1473 
  Haemophilus 
influenzae Type B 5 6 3 4 6 5 2         1   2 1 2 1 1 3 0 1 
  Hansen's disease 
(Leprosy)           1   2 1       1 1   1   1     1  
  Hantavirus 
syndromes         2 1 2       1         1     1 1  
 Hepatitis A (viral, 
infectious) 58 64 106 346 490 400 161 67 41 72 40 50 22 13 48 109 38 11 8 7 17  
 Hepatitis B 
(serum) acute 
/chronic 36 27 46 74 44 54 44 38 24 20 27 17 32 21/35 269 25/226 293 15/183 15/182 12/227 11/276 
Hepatitis B 
(perinatal)                           1   1   1       
  Hepatitis C or 
unspecified 12 25 1 43           1 1           262 156 48 297 3 
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* includes cases starting 2011 
** Hep C cases were not all entered due to limited staffing
Notifiable 
diseases 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
 
 
2008 2009 2010 2011 2012 2013 
  HIV (diagnosis)         70  73 64 92 95 105 89 105 113 108 124 101 126 115 119 117 122 
  Legionellosis 19 34 21 11 12 11 17 15 8 13 12 8 8 13 12 21 24 16 11 13 11 
  Listeria 
monocytogenes       1   2 6 2 3 5   3 7 6 8 1 4 3 5 3 2 
  Lyme disease 8 17 16 19 8 27 24 34 36 42 58 56 91 97 124 109 108 87 100 165 247 
  Malaria 5 5 3 3 10 8 11 2 9 4 6 5 9 2 3 12 10 14 22 6 12 
Measles (Rubeola)   7   1               3         1   1 0   
  Meningococcal 
invasive disease 28 25 31 56 47 46 42 37 32 29 28 17 19 20 15 19 16 10 14 2 1 
Mumps 11 16 11 3 10 11 8 8 1 1 2 2 6 1,963 27 24 15 38 8 6 3 
Pertussis 
(whooping cough) 38 23 11 32 207 78 111 67 167 230 182 1066 1106 342 150 257 235 705 232 1736 308 
  Plague                                           
Poliomyelitis                                           
  Psittacosis 2               3       1                 
Rabies, animal 78 90 141 237 160 153 159 81 83 74 105 100 108 57 31 29 35 27 25 31 12 
Rabies, human                   1                       
  Rocky Mountain 
spotted fever 7 1   1 2 2 1 2 5 7 3 2 7 5 17 8 5 5 7 8 8 
Rubella (German 
Measles)             30   1                         
  Salmonellosis 242 404 433 335 296 375 260 373 339 509 413 435 410 475 477 425 408 530 448 622 575 
  Shigellosis 68 338 351 151 90 69 74 569 367 122 93 64 103 134 109 214 53 57 18 91 342 
Syphilis 175 235 171 91 65 25 31 55 45 56 43 36 29 68 64 75 65 68 70 138 226 
Tetanus 1 1     1 1   1   1     1         1      1 
  Toxic Shock 
Syndrome 7 8 5 4 3 4 4 4 1 3 5 5 5     1 2 1 1 1 1 
  Trichinosis   1 6           3       1                 
Tuberculosis 58 66 67 70 74 55 58 37 42 31 40 47 55 36   46 42 48 40 46 47 
Tularemia                                 1   3 1 4 
Typhoid fever       1 1   1       2       1 6   3 4 3 1 
  West Nile virus                   52 147 23 37 37 30 5 5 9 9 31 44 
  Yellow Fever                                 2         
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Table 15. Salmonella serotypes reported, 2013 
Salmonella Serotype Cases   Serotype Cases 
Salmonella Agona           6 Salmonella Ohio 1 
Salmonella Anatum 2 Salmonella Oranienburg     8 
Salmonella Bareilly 1 Salmonella Panama 1 
Salmonella Berta 10 Salmonella Paratyphi A 1 
Salmonella Bonariensis 1 Salmonella Poona 3 
Salmonella Bovismorbificans 6 Salmonella Putten 1 
Salmonella Braenderup 11 Salmonella Reading 8 
Salmonella Derby 2 Salmonella Saintpaul       10 
Salmonella Enteritidis    95 Salmonella Sandiego 1 
Salmonella Hadar 1 Salmonella Schwarzengrund 4 
Salmonella Hartford 8 Salmonella Thompson        10 
Salmonella Heidelberg       6 Salmonella Typhi 1 
Salmonella Infantis        11 Salmonella Typhimurium 84 
Salmonella Javiana      6 Salmonella Uganda 2 
Salmonella London 1 Salmonella Species 2 
Salmonella Mbandaka         3 Salmonella Subspecies I 71 
Salmonella Montevideo 17 Salmonella Subspecies IIIb 4 
Salmonella Muenchen 7 Salmonella Subspecies IV 2 
Salmonella Muenster 2 Salmonella Subspecies V 1 
Salmonella Newmexico 1   Unknown 139 
Salmonella Newport        24 Total   575 
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Table 16. Shigella serogroups,  1991-2013 
Shigella  
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
Serogroups 
Boydii   1     1 1       4 6 2   3 1 1 0 1 1 2 1 0 0 
Dysenteriae 1 1       1                   1 0 0 0 0 0 0 2 
Flexneri 8 8 8   3 13 12 6 7 10 7 11 5 8 7 15 9 11 7 6 4 5 3 
Group B           3   1 1           3   2 0 0 0 0 0 0 
Group C       1                         2 0 0 0 0 0 0 
Group D   1   4 3 5   1         1       1 1 0 0 0 10 0 
Sonnei 24 33 50 199 119 116 62 44 55 514 306 63 62 41 58 110 97 136 45 49 10 73 184 
Unknown                   41 46 46 25 12 7 7 0 0 0 0 3 3 153 
TOTAL 
CASES 33 46 68 338 351 151 90 69 74 569 365 122 93 64 78 134 109 214 53 57 18 91 342 
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Table 17. 2013 Iowa adult blood testing summary by county 
COUNTY # tested # BLL result > 10 µg/dL COUNTY # tested  # BLL result > 10 µg/dL COUNTY   # tested # BLL result > 10 µg/dL 
Adair  4 0 Floyd  4 0 Monona 5 0 
Adams 5 2 Franklin 3 0 Monroe 14 9 
Allamakee 6 0 Fremont 7 2 Montgomery 48 26 
Appanoose 55 39 Greene 11 0 Muscatine 71 4 
Audubon 4 2 Grundy 9 1 O’Brien 6 0 
Benton 13 3 Guthrie 7 0 Osceola 1 0 
Black Hawk  89 3 Hamilton 13 0 Page 24 8 
Boone  20 0 Hancock 8 1 Palo Alto 6 0 
Bremer  14 0 Hardin 16 0 Plymouth 6 0 
Buchanan  57 38 Harrison 10 0 Pocahontas 4 1 
Buena Vista 5 2 Henry 13 0 Polk 288 3 
Butler 7 1 Howard 4 0 Pottawattamie 38 1 
Calhoun 8 0 Humboldt 3 0 Poweshiek 15 0 
Carroll 22 0 Ida 1 0 Ringgold 4 0 
Cass  6 2 Iowa 6 0 Sac 10 0 
Cedar 17 1 Jackson 23 5 Scott  340 20 
Cerro Gordo 25 0 Jasper 21 0 Shelby 2 1 
Cherokee 3 0 Jefferson 61 17 Sioux 6 1 
Chickasaw  4 0 Johnson 83 3 Story 54 2 
Clarke 4 2 Jones 19 5 Tama 10 0 
Clay 2 0 Keokuk 18 4 Taylor 5 0 
Clayton 71 52 Kossuth 7 0 Union 4 1 
Clinton 78 4 Lee 29 1 Van Buren 5 0 
Crawford 4 0 Linn 167 16 Wapello 51 12 
Dallas 27 0 Louisa 15 2 Warren 29 4 
Davis 3 1 Lucas 48 34 Washington 19 0 
Decatur 13 8 Lyon 3 0 Wayne 146 109 
Delaware 288 250 Madison 9 1 Webster 33 1 
Des Moines 17 1 Mahaska 53 9 Winnebago 4 0 
Dickinson 9 0 Marion 12 0 Winneshiek 16 0 
Dubuque 180 112 Marshall 25 1 Woodbury 65 7 
Emmet 7 0 Mills 17 4 Worth 2 0 
Fayette  36 15 Mitchell 4 2 Wright 7 0 
Based on highest test result in 2013 per adult (16 yo at time of test) residing in Iowa.1An elevated blood lead level (EBL) is considered a venous result greater than 
or equal to 10 micrograms per deciliter (µg/dL). Total including suppressed data 
 
3170 
 
856 
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Table 18. Common notifiable diseases by county, 2013 
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ADAIR 0 0 3 9  10 2 0 0 3  0 0 0 0 0 0 0 0 0 1 0 0 0 1 0  0 0 
ADAMS 0 0 1 7  0 1 0 0 0  0 0 0 0 0 0 0 0 0 3 0 0 0 0 0  0 0 
ALLAMAKEE 0 0 10 14  5 0 0 0 0  0 0 0 1 0 0 9 0 0 0 0 0 7 1 0  0 0 
APPANOOSE 0 0 0 28  5 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 1 0 0  0 0 
AUDUBON 0 0 0 21  1 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 0 1 0  0 1 
BENTON 1 1 12 62  13 2 0 7 1  0 0 0 1 0 0 4 0 0 2 0 0 9 0 1  0 0 
BLACK HAWK 5 11 16 878  17 2 1 8 89  0 0 0 26 1 0 6 0 0 11 0 1 
2
6 1 9  4 0 
BOONE 0 0 3 68  19 0 0 3 6  0 0 0 0 0 0 4 1 0 2 1 0 8 0 1  0 0 
BREMER 0 0 3 76  12 1 1 5 4  0 0 0 0 0 0 3 0 0 0 0 0 3 0 0  0 0 
BUCHANAN 0 1 9 46  6 0 0 1 5  0 0 0 0 0 0 3 0 0 0 0 0 3 0 3  0 0 
BUENA VISTA 2 5 8 49  0 1 0 1 1  0 0 0 5 0 0 0 0 0 2 1 0 4 0 0  1 0 
BUTLER 0 0 4 41  3 2 0 1 2  0 0 0 0 0 0 2 0 0 0 0 0 1 0 1  0 0 
CALHOUN 0 0 0 29  8 0 0 2 6  0 0 0 0 0 0 0 0 0 2 0 0 2 0 0  0 0 
CARROLL 0 1 2 51  11 6 0 1 2  0 0 0 2 0 0 0 0 0 13 0 0 4 0 0  0 0 
CASS 0 0 4 32  0 1 0 1 1  0 0 0 0 0 0 1 0 0 5 0 0 3 0 0  0 1 
CEDAR 0 1 5 43  2 1 0 0 3  0 0 0 0 0 0 0 0 1 0 0 0 3 0 1  0 0 
CERRO GORDO 0 1 8 71  10 0 0 3 6  0 0 0 1 0 0 1 0 0 4 0 0 
1
2 0 0  1 0 
CHEROKEE 0 0 1 28  1 3 0 0 3  0 0 0 1 0 0 0 0 0 0 0 0 0 0 0  0 0 
CHICKASAW 0 0 5 15  1 0 1 1 0  0 0 0 0 0 0 1 0 0 0 0 0 3 0 0  0 0 
CLARKE 1 1 1 33  7 1 0 1 1  0 0 0 1 0 0 0 0 0 2 0 0 0 1 0  0 0 
CLAY 0 0 3 35  1 1 0 0 4  0 0 0 1 0 0 0 0 0 1 0 0 1 0 0  0 0 
CLAYTON 0 0 5 25  3 3 0 2 0  0 0 0 0 0 0 17 0 0 0 0 0 4 0 0  0 0 
CLINTON 0 1 1 172  4 1 0 2 12  0 3 1 1 0 0 2 0 1 0 1 0 7 1 3  0 0 
CRAWFORD 0 0 5 55  2 1 0 1 0  0 0 0 3 0 0 0 0 0 2 0 0 2 1 0  0 2 
DALLAS 1 2 5 117  42 4 0 10 13  0 0 2 5 0 0 1 0 0 4 0 0 8 1 5  2 2 
Iowa Department of Public Health 
 52 
 
  
A
ID
S 
(d
ia
gn
o
si
s)
 
H
IV
 (
d
ia
gn
o
si
s)
 
C
A
M
P
Y 
C
H
LA
M
YD
IA
 
C
R
YP
TO
 
E.
C
O
LI
 S
H
G
T 
EH
R
LI
C
H
 (
H
M
E)
 
G
IA
R
D
IA
 
G
O
N
O
R
R
H
EA
 
H
U
S 
H
EP
 A
 
H
EP
 B
, A
C
U
TE
 
H
EP
 B
, C
H
R
O
N
 
LE
G
IO
N
 
LI
ST
ER
IA
 
LY
M
E 
M
EN
IN
G
O
.I
N
F 
M
U
M
P
S 
P
ER
TU
SS
IS
 
R
A
B
IE
S 
(A
N
IM
A
L)
 
R
M
SF
 
SA
LM
 
SH
IG
EL
LA
 
SY
P
H
IL
IS
 
TB
 
W
ES
T 
N
IL
E 
V
IR
U
S 
DAVIS 0 0 0 17  3 1 0 1 2  1 0 0 0 0 0 1 0 0 12 0 0 2 0 0  0 0 
DECATUR 0 0 4 15  4 1 0 2 2  0 0 0 0 0 0 1 0 0 0 0 0 1 0 0  0 0 
DELAWARE 0 0 14 58  25 4 0 2 3  0 1 0 0 0 0 7 0 0 1 0 0 1 0 0  1 0 
DES MOINES 0 0 9 189  13 3 0 6 32  0 0 0 3 0 0 5 0 0 2 0 0 5 0 1  0 0 
DICKINSON 0 0 1 24  1 1 0 2 1  0 1 0 0 1 0 0 0 0 0 0 0 1 0 0  0 1 
DUBUQUE 5 6 49 377  38 10 0 11 45  0 0 0 3 0 0 29 0 0 5 0 0 25 1 4  2 0 
EMMET 0 0 1 30  1 0 0 1 4  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 
FAYETTE 0 0 14 27  4 0 1 1 3  0 0 0 0 0 0 1 0 0 0 1 0 3 0 0  0 1 
FLOYD 0 0 4 32  7 2 0 1 1  0 0 0 1 0 0 1 0 0 0 0 0 4 0 0  0 0 
FRANKLIN 0 0 0 27  1 0 0 0 3  0 0 0 0 0 0 0 0 0 0 0 0 2 0 0  0 0 
FREMONT 0 0 0 9  1 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 1 4 0 0  0 1 
GREENE 1 1 0 20  6 0 0 0 0  0 0 0 1 0 0 0 0 0 0 0 0 0 1 0  0 0 
GRUNDY 0 0 5 23  8 0 0 2 2  0 0 0 0 0 0 0 0 0 0 0 0 3 0 0  0 0 
GUTHRIE 2 1 1 15  2 0 0 4 0  0 0 0 0 0 0 0 0 0 1 0 0 1 0 1  0 0 
HAMILTON 0 0 7 45  6 2 0 1 5  0 0 0 2 0 0 1 0 0 1 0 0 10 0 1  0 1 
HANCOCK 0 0 4 7  1 0 0 1 0  0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  0 0 
HARDIN 0 0 2 43  3 1 0 0 6  0 0 0 1 0 0 3 0 0 0 0 0 1 0 0  0 0 
HARRISON 0 0 5 41  4 2 0 0 1  0 0 0 0 0 0 0 0 0 1 0 0 4 2 0  0 1 
HENRY 0 0 2 56  3 0 0 0 1  0 2 0 0 0 0 1 0 0 4 0 0 7 0 0  0 0 
HOWARD 0 0 1 9  4 0 0 0 0  0 0 0 0 0 0 1 0 0 0 0 0 6 0 0  0 0 
HUMBOLDT 0 0 0 20  21 0 0 0 2  0 0 0 0 0 0 0 0 0 0 0 0 5 0 0  0 2 
IDA 0 0 3 9  0 0 0 0 0  0 0 0 0 0 0 0 0 0 0 0 0 4 0 0  0 1 
IOWA 0 0 3 45  0 3 0 1 1  0 0 0 0 0 0 5 0 0 0 0 0 3 0 2  0 0 
JACKSON 0 0 22 42  7 3 0 2 3  0 0 0 1 0 0 12 0 0 0 0 0 2 0 1  0 0 
JASPER 0 0 3 103  34 5 0 6 13  0 0 1 0 0 0 1 0 0 3 0 1 8 0 0  0 1 
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JEFFERSON 0 0 1 31  2 3 0 2 3  0 0 0 2 0 0 0 0 0 0 0 0 2 0 2  2 0 
JOHNSON 7 12 16 637  37 12 0 22 85  0 1 0 17 0 0 40 0 1 16 0 1 10 7 13  7 0 
JONES 1 1 16 55  9 1 0 3 5  0 0 0 1 0 0 0 0 0 0 0 0 5 0 2  0 0 
KEOKUK 0 1 1 16  6 0 0 2 5  0 0 0 0 0 0 0 0 0 0 0 0 3 0 2  0 0 
KOSSUTH 0 0 1 27  1 0 0 0 2  0 1 0 0 0 0 0 0 0 1 0 0 3 6 0  0 1 
LEE 0 0 3 126  5 2 1 2 2  0 0 0 0 0 1 0 0 0 1 1 0 11 0 0  0 0 
LINN 9 17 44 954  87 8 0 15 125  0 0 0 19 1 0 15 0 0 25 1 0 42 4 23  3 1 
LOUISA 0 0 1 22  2 0 0 0 1  0 0 0 0 0 0 0 0 0 0 0 0 1 0 0  2 0 
LUCAS 0 0 3 16  7 0 0 0 5  0 0 0 2 0 0 1 0 0 1 0 0 0 0 2  0 0 
LYON 0 0 14 15  1 2 0 3 0  0 0 1 0 0 0 0 0 0 0 0 0 3 0 0  0 2 
MADISON 0 0 2 28  32 1 0 0 3  0 0 0 1 0 0 1 0 0 7 0 1 5 1 1  0 0 
MAHASKA 0 1 4 70  6 4 0 0 4  0 0 0 1 0 0 1 0 0 1 0 0 4 0 2  0 0 
MARION 1 1 5 40  20 1 0 0 1  0 0 0 5 0 0 4 0 0 0 0 0 7 1 1  0 0 
MARSHALL 0 0 5 189  5 1 0 2 14  0 0 0 8 0 0 1 0 0 2 0 0 10 0 3  0 0 
MILLS 0 0 1 23  0 1 0 2 6  0 0 0 1 0 0 0 0 0 0 0 0 2 0 0  0 0 
MITCHELL 0 0 2 6  7 1 0 0 1  0 0 0 0 0 0 0 0 0 1 0 0 0 0 0  0 0 
MONONA 0 0 2 15  4 1 0 2 2  0 0 0 0 0 0 0 0 0 0 0 0 1 1 0  0 4 
MONROE 0 0 4 30  5 2 0 0 1  0 0 0 0 0 0 1 0 0 0 0 0 0 0 0  0 1 
MONTGOMERY 0 0 3 20  1 0 0 0 1  0 0 0 0 0 0 0 0 0 0 0 0 0 1 0  0 2 
MUSCATINE 0 1 6 146  1 2 0 1 9  0 0 0 5 1 0 8 0 0 0 0 0 6 1 1  1 0 
O'BRIEN 0 0 6 21  0 0 0 2 0  0 0 0 0 0 0 0 0 0 0 0 0 8 1 0  0 0 
OSCEOLA 0 0 1 3  1 0 0 0 1  0 0 0 0 0 0 0 0 0 0 1 0 1 0 0  0 0 
PAGE 0 0 1 46  3 1 0 1 3  0 1 0 1 0 0 0 0 0 0 1 0 5 0 0  0 0 
PALO ALTO 0 1 0 15  2 0 0 0 2  0 0 1 1 0 0 0 0 0 1 0 0 2 0 0  0 0 
PLYMOUTH 0 1 10 42  14 2 0 2 2  0 0 0 0 0 0 0 0 0 2 1 0 6 2 2  0 1 
POCAHONTAS 0 0 1 12  4 0 0 0 1  0 0 0 0 0 0 0 0 0 0 0 0 0 0 4  0 0 
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POLK 27 30 40 1,978 541 23 1 61 389 3 2 4 104 5 0 8 0 0 47 0 1 59 9 67 9 0 
POTTAWATTAMIE 0 0 8 396 14 2 0 1 85 0 1 0 3 0 0 1 0 0 3 0 0 14 23 4 1 4 
POWESHIEK 0 0 6 51 2 0 0 1 5 0 0 0 1 0 0 2 0 0 0 0 0 4 0 1 0 0 
RINGGOLD 0 0 1 6 4 2 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 1 
SAC 0 0 8 8 9 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 1 2 0 0 0 
SCOTT 12 14 10 945 12 8 0 6 146 0 0 1 11 0 0 12 0 0 43 1 0 26 2 27 4 1 
SHELBY 0 1 0 20 2 0 0 1 1 0 0 0 2 0 0 0 0 0 0 0 0 1 0 1 0 1 
SIOUX 0 1 20 38 9 2 0 15 3 0 1 0 0 0 0 0 0 0 6 1 0 16 1 1 0 0 
STORY 2 3 11 312 32 3 0 4 33 0 0 0 10 0 0 3 0 0 10 0 1 16 2 15 2 0 
TAMA 0 0 2 62 3 0 0 0 3 0 0 0 2 0 0 0 0 0 1 0 0 4 0 0 1 0 
TAYLOR 0 0 2 10 1 1 0 0 2 0 0 0 0 0 0 0 0 0 4 0 0 1 0 0 0 0 
UNION 0 0 0 38 4 0 0 1 2 0 0 0 1 0 0 0 0 0 0 0 0 4 0 1 0 0 
VAN BUREN 0 0 0 14 6 0 1 0 0 0 0 0 0 0 0 0 0 0 3 0 0 4 0 2 0 1 
WAPELLO 0 0 18 260 33 0 0 6 35 0 0 0 4 0 0 2 0 0 2 0 0 2 0 0 2 0 
WARREN 1 2 3 115 55 4 0 4 12 0 0 0 0 0 0 0 0 0 18 0 0 8 0 0 0 0 
WASHINGTON 0 0 5 53 5 2 0 0 4 1 2 0 0 1 0 3 0 0 7 0 0 6 4 0 0 0 
WAYNE 0 0 3 7 1 1 0 0 1 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 
WEBSTER 1 0 8 200 108 0 0 14 82 0 1 0 5 0 0 3 0 0 11 0 0 14 0 2 0 0 
WINNEBAGO 0 0 0 9 1 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 
WINNESHIEK 0 0 9 34 3 1 1 1 2 0 0 0 1 0 0 13 0 0 1 0 1 7 0 0 1 0 
WOODBURY 3 2 28 523 14 5 0 4 89 1 0 0 7 0 1 3 0 0 5 1 0 34 262 12 1 9 
WORTH 0 0 1 5 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
WRIGHT 0 0 6 29 3 0 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 2 0 0 0 0 
Total 82 122 610 11,006 1505 171 8 275 1,473 6 17 11 276 11 2 247 1 3 308 12 8 575 342 226 47 44 
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